[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "A synonym for Acrokeratosis paraneoplastica is \"acrokeratosis paraneoplastic syndrome\"."
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that affect brain development and can cause intellectual disability, growth delays, and other physical abnormalities. However, they are distinct conditions with different genetic causes and clinical features.\nWeaver syndrome is caused by mutations in the PHLPP2 gene, which codes for a protein involved in the regulation of protein phosphatase 1 (PP1). PP1 is a key enzyme that regulates various cellular processes, including cell signaling, protein synthesis, and DNA repair. Weaver syndrome is characterized by intellectual disability, seizures, delayed speech and language development, and a distinctive facial appearance with a prominent forehead, widely spaced eyes, and a small jaw.\nSotos syndrome, on the other hand, is caused by mutations in the NSD1 gene, which codes for a protein involved in the regulation of chromatin structure and gene expression. Sotos syndrome is characterized by intellectual disability, growth delays, distinctive facial features, and an increased risk of various medical problems, including heart defects, vision problems, and immune system disorders.\nWhile both Weaver syndrome and Sotos syndrome can cause intellectual disability and growth delays, the clinical features of the two conditions are distinct. Weaver syndrome typically presents with more mild symptoms, while Sotos syndrome can have more severe and widespread effects on brain development and function."
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "JASPAR (Junket Algorithm for the Prediction of Transcription Factor Binding Sites in DNA) is a widely used database of transcription factor binding site (TFBS) predictions. Here are some of the major releases of the JASPAR database:\n1. JASPAR Release 1.0 (1999): This was the first release of the JASPAR database, which contained TFBS predictions for 17 transcription factors.\n2. JASPAR Release 2.0 (2003): This release expanded the database to include predictions for 61 transcription factors and introduced a new algorithm for predicting TFBSs.\n3. JASPAR Release 3.0 (2007): This release included improvements to the prediction algorithms and the addition of new transcription factors, bringing the total number of predicted TFBSs to 147.\n4. JASPAR Release 4.0 (2010): This release introduced a new feature called \"JASPAR-TS,\" which allows users to predict the binding sites of transcription factors in a given DNA sequence.\n5. JASPAR Release 5.0 (2013): This release included improvements to the prediction algorithms and the addition of new transcription factors, bringing the total number of predicted TFBSs to 213.\n6. JASPAR Release 6.0 (2016): This release introduced a new algorithm for predicting TFBSs and improved the accuracy of the predictions.\n7. JASPAR Release 7.0 (2019): This release included the integration of new data and improved algorithms, leading to more accurate predictions of TFBSs.\n8. JASPAR Release 8.0 (2022): This is the latest release of the JASPAR database, which includes improvements to the prediction algorithms and the addition of new transcription factors, bringing the total number of predicted TFBSs to 333.\nIt's worth noting that the JASPAR database has been updated regularly since its inception, with new releases incorporating new data and improvements to the prediction algorithms."
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The KP4 protein is a protein encoded by the KP4 gene in the herpes simplex virus (HSV). It is a key regulator of the viral lytic cycle and plays a crucial role in the transition from the latent to the lytic phase of infection. The KP4 protein inhibits the activity of the viral gene expression machinery, specifically the transcriptional activator ICP0, and thereby prevents the expression of early lytic genes. In addition, KP4 protein also interacts with and inhibits the activity of the viral DNA polymerase, further contributing to the regulation of viral gene expression."
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "Yes, DITPA (N-[4-[2-(7-Chloro-2-quinolinyl)ethyl]phenyl]-1,3,5-triazacyclohexane-2,4,6-trione) is a synthetic thyroid hormone analog that has been utilized in both experimental and clinical studies. DITPA is a potent agonist of the thyroid hormone receptor, and it has been used to investigate the role of thyroid hormones in various physiological processes, including metabolism, growth, and development.\nIn experimental studies, DITPA has been used to:\n1. Investigate the mechanisms of thyroid hormone action: DITPA has been used to study the effects of thyroid hormones on various cellular processes, including gene expression, protein synthesis, and metabolism.\n2. Model thyroid hormone deficiencies: DITPA has been used to study the effects of thyroid hormone deficiencies on various physiological processes, such as growth and development.\n3. Investigate the role of thyroid hormones in cancer: DITPA has been used to study the effects of thyroid hormones on cancer cell growth and development.\n4. Evaluate the efficacy of thyroid hormone replacement therapy: DITPA has been used to evaluate the efficacy of thyroid hormone replacement therapy in treating hypothyroidism.\nIn clinical studies, DITPA has been used to:\n1. Diagnose hypothyroidism: DITPA has been used to diagnose hypothyroidism in patients with thyroid hormone deficiencies.\n2. Monitor thyroid hormone replacement therapy: DITPA has been used to monitor the effectiveness of thyroid hormone replacement therapy in treating hypothyroidism.\n3. Investigate the effects of thyroid hormones on various diseases: DITPA has been used to investigate the effects of thyroid hormones on various diseases, including cancer, cardiovascular disease, and cognitive function.\nOverall, DITPA is a valuable tool for investigating the mechanisms of thyroid hormone action and for evaluating the efficacy of thyroid hormone"
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "COUGER (Cytoscape Ontology-based Gene Regulatory Event) is a tool in the Cytoscape platform that allows users to analyze and visualize gene regulatory events, such as gene expression, promoter methylation, and histone modification, in a genomic context. It provides a framework for understanding the complex interactions between genetic and epigenetic events and their impact on gene expression.\nCOUGER integrates data from various sources, including ChIP-seq, RNA-seq, and methylation array data, and uses ontologies to organize and interpret the data. It can be used to identify patterns and trends in gene regulation, to predict the effects of genetic or epigenetic changes on gene expression, and to identify potential drug targets or therapeutic strategies.\nIn summary, COUGER is a powerful tool for analyzing and interpreting gene regulatory events in a genomic context, and can be used to gain insights into the complex interactions between genetic and epigenetic factors and their impact on gene expression."
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "Yes, there are drugs available for the treatment of tick-borne encephalitis (TBE). The most commonly used drugs for TBE include:\n1. Antiviral medications: Ribavirin, an antiviral drug, is the most commonly used treatment for TBE. It can help reduce the severity of symptoms and shorten the duration of illness.\n2. Corticosteroids: Corticosteroids, such as prednisone, may be prescribed to reduce inflammation in the brain and alleviate symptoms such as headache, fever, and confusion.\n3. Immunoglobulins: In some cases, immunoglobulins (antibodies) may be given to help boost the body's immune system and fight the virus.\n4. Supportive care: Supportive care, such as intravenous fluids, oxygen therapy, and pain management, may also be provided to help manage symptoms and prevent complications.\nIt is important to note that the choice of treatment depends on the severity and location of the infection, as well as the patient's overall health. In some cases, a combination of these treatments may be used. It is important to consult a healthcare professional for proper diagnosis and treatment."
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "There are several genome browsers and databases available for DNA shape annotations. Some of the popular ones include:\n1. 4D-Nucleome: A comprehensive database of 3D chromatin structures in various organisms, including humans.\n2. Hi-C: A database of chromosome conformation capture (3C) data, which provides information on the spatial proximity of genomic regions.\n3. Chromosome Conformation and Dynamics (ChiCD): A database of chromosome conformation capture (3C) data, which provides information on the spatial proximity of genomic regions.\n4. 3D Genome Browser: A web-based tool for visualizing and analyzing 3D chromatin structures in various organisms.\n5. Genome3D: A database of 3D chromatin structures in various organisms, including humans.\n6. Chromatin Interaction Map (ChIA-Map): A database of chromosome conformation capture (3C) data, which provides information on the spatial proximity of genomic regions.\n7. Topological Domain Database (TOPO-DB): A database of topological domain structures in various organisms, which provides information on the 3D organization of chromosomes.\n8. Chromosome Structure and Function (CSF): A database of 3D chromatin structures in various organisms, including humans.\nThese databases provide valuable information on the spatial organization of chromosomes and its implications for gene regulation, chromosome stability, and cellular function."
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "The EZH2 gene has been associated with several syndromes, including:\n1. Rubinstein-Taybi syndrome: This is a rare genetic disorder characterized by intellectual disability, growth retardation, facial dysmorphism, and various other congenital anomalies. EZH2 mutations are found in approximately 50% of Rubinstein-Taybi syndrome cases.\n2. Pallister-Hall syndrome: This is a rare genetic disorder characterized by intellectual disability, short stature, facial dysmorphism, and various other congenital anomalies. EZH2 mutations are found in approximately 20% of Pallister-Hall syndrome cases.\n3. Coffin-Lowry syndrome: This is a rare genetic disorder characterized by intellectual disability, growth retardation, facial dysmorphism, and various other congenital anomalies. EZH2 mutations are found in approximately 10% of Coffin-Lowry syndrome cases.\n4. Smith-Magenis syndrome: This is a rare genetic disorder characterized by intellectual disability, growth retardation, facial dysmorphism, and various other congenital anomalies. EZH2 mutations have been identified in a small proportion of Smith-Magenis syndrome cases.\n5. Cri du chat syndrome: This is a rare genetic disorder characterized by a distinctive cry at birth, intellectual disability, growth retardation, and various other congenital anomalies. EZH2 mutations have been identified in a small proportion of Cri du chat syndrome cases.\nIt's worth noting that the frequency and distribution of EZH2 mutations may vary depending on the specific syndrome and the size and population of the study."
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition, including:\n1. p53: The tumor suppressor protein p53 undergoes a dimer-to-tetramer transition in response to DNA damage, leading to the activation of its transcriptional activity.\n2. c-Jun: The transcription factor c-Jun also undergoes a dimer-to-tetramer transition, which is involved in the regulation of gene expression and cellular proliferation.\n3. FosB: The transcription factor FosB is a downstream target of the signaling pathway activated by chronic exposure to stressors such as corticosteroids, and it undergoes a dimer-to-tetramer transition in response to these signals.\n4. CREB: The transcription factor CREB (cAMP-response element-binding protein) undergoes a dimer-to-tetramer transition in response to changes in intracellular cAMP levels, leading to the activation of its transcriptional activity.\n5. NF-κB: The transcription factor NF-κB (nuclear factor kappa B) undergoes a dimer-to-tetramer transition in response to signals such as cytokines and growth factors, leading to the activation of its transcriptional activity.\n6. STAT3: The transcription factor STAT3 (signal transducer and activator of transcription 3) undergoes a dimer-to-tetramer transition in response to signals such as cytokines and growth factors, leading to the activation of its transcriptional activity.\n7. HIF1α: The transcription factor HIF1α (hypoxia-inducible factor 1 alpha) undergoes a dimer-to-tetramer transition in response to changes in oxygen availability, leading to the activation of its transcriptional activity.\n8. FOXO: The transcription factor FOXO (forkhead box O) undergoes a dimer-to-tetramer transition in response to changes in cellular redox state, leading to the activation of its transcriptional activity.\n9. PPARγ: The"
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is BCL-2 (B-cell lymphoma 2). BCL-2 is a family of proteins that play a crucial role in regulating apoptosis by modulating the permeability of the outer mitochondrial membrane, allowing cytochrome c to release and activate caspases. BCL-2 has been shown to interact with PLN and prevent its ubiquitination and degradation, thereby inhibiting apoptosis."
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people. Here are some examples:\n1. A 2010 Cochrane review of 16 randomized controlled trials found that vitamin D supplementation significantly reduced the risk of falls in older adults, with a pooled relative risk reduction of 37% (95% CI 23-52).\n2. A 2012 randomized controlled trial published in the Journal of the American Geriatrics Society found that vitamin D and calcium supplementation reduced the incidence of falls in community-dwelling older adults with vitamin D deficiency (n=120).\n3. A 2014 randomized controlled trial published in the Journal of Gerontology found that vitamin D supplementation reduced the incidence of falls in older adults with cognitive impairment (n=137).\n4. A 2016 meta-analysis published in the Journal of Bone and Mineral Research found that vitamin D supplementation was associated with a reduced risk of falls in older adults (n=36,329).\nIt is important to note that while these studies suggest a potential benefit of vitamin D supplementation in reducing the incidence of falls in older people, the evidence is not yet conclusive, and more research is needed to confirm these findings and establish the optimal dosage and duration of supplementation. Additionally, it is important to consult with a healthcare professional before starting any supplement regimen."
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Studies have shown that Jarid2 is a direct target of miR-155 and that miR-155 regulates Jarid2 expression in Th17 cells. This regulation plays a crucial role in the differentiation and function of Th17 cells, which are involved in the immune response to infection and inflammation."
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "The human HoxD cluster contains 9 genes: Hoxd-1 to Hoxd-9."
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "Casein kinase 1 (CK1) is a serine/threonine kinase that plays a crucial role in various cellular processes, including signal transduction, metabolism, and gene regulation. The phosphorylation consensus motifs for CK1 are:\n1. Ser/Thr-Pro-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the catalytic subunit of CK1 and is involved in the phosphorylation of downstream targets.\n2. Ser/Thr-Gly-X-X-Ser/Thr\nThis motif is also recognized by the catalytic subunit of CK1 and is involved in the phosphorylation of downstream targets.\n3. Ser-X-X-Ser/Thr-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the regulatory subunit of CK1 and is involved in the activation of the enzyme by binding to specific phosphorylation sites.\n4. Ser-X-X-X-Ser/Thr-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the regulatory subunit of CK1 and is involved in the regulation of CK1 activity.\nIt's worth noting that these consensus motifs are not exclusive to CK1 and can be found in other kinases as well."
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH (aspartate beta-hydroxylase) gene in humans encodes several different proteins/isoforms, including:\n1. Aspartate beta-hydroxylase (ASPH): This is the primary isoform encoded by the ASPH gene, which plays a crucial role in the biosynthesis of the neurotransmitter serotonin.\n2. Tissue inhibitor of metalloproteinases 1 (TIMP1): A splice variant of the ASPH gene, TIMP1 is a potent inhibitor of matrix metalloproteinases (MMPs), which are enzymes involved in the breakdown of the extracellular matrix.\n3. Neprilysin (NEP): A splice variant of the ASPH gene, NEP is a protease that degrades various neurotransmitters, including serotonin, dopamine, and norepinephrine.\n4. Prothrombin (F2): A splice variant of the ASPH gene, Prothrombin is a clotting factor in the blood coagulation cascade.\nThese different isoforms/proteins are produced through alternative splicing of the ASPH gene, which allows for the generation of multiple functional proteins from a single gene."
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "Empagliflozin was FDA approved on June 28, 2014."
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis leads to various developmental and physiological abnormalities, including:\n1. Delayed seed germination and seedling growth: Lon1-deficient plants have slower seed germination and reduced seedling growth compared to wild-type plants.\n2. Altered leaf morphology: Lon1-deficient leaves are often smaller and have a different shape than those of wild-type plants.\n3. Reduced stem elongation: Lon1-deficient stems are shorter than those of wild-type plants, indicating a role for Lon1 in regulating stem elongation.\n4. Impaired flowering time: Lon1-deficient plants flower later than wild-type plants, suggesting a role for Lon1 in regulating floral development.\n5. Increased sensitivity to abiotic stress: Lon1-deficient plants are more sensitive to drought and salt stress than wild-type plants, indicating a role for Lon1 in protecting against stress.\n6. Altered hormone regulation: Lon1-deficient plants have altered levels of various hormones, including ethylene, auxin, and cytokinin, which may contribute to the observed developmental abnormalities.\n7. Changes in gene expression: Lon1-deficient plants exhibit altered expression of various genes involved in different cellular processes, including cell division, differentiation, and stress response.\n8. Increased DNA damage: Lon1-deficient plants have higher levels of DNA damage, as indicated by increased levels of DNA double-strand breaks and impaired repair of these breaks.\n9. Reduced tolerance to oxidative stress: Lon1-deficient plants are more susceptible to oxidative stress, as indicated by increased levels of reactive oxygen species (ROS) and reduced levels of antioxidant enzymes.\n10. Altered protein function: Lon1-deficient plants have altered levels and activity of various proteins involved in different cellular processes, including protein degradation, protein synthesis, and protein folding."
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, linker histones are present in the yeast genome. In fact, yeast has three linker histones: H3K5ac, H3K27ac, and H3K4me3. These linker histones play a crucial role in organizing chromatin structure and regulating various cellular processes, including transcriptional elongation, gene expression, and DNA repair."
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "There is some evidence to suggest that drinking tomato juice may help lower cholesterol levels. Tomato juice contains a compound called lycopene, which has been shown to have cholesterol-lowering properties.\nLycopene is a powerful antioxidant that has been shown to reduce the amount of low-density lipoprotein (LDL) cholesterol, also known as \"bad\" cholesterol, in the blood. High levels of LDL cholesterol are associated with an increased risk of heart disease, so reducing these levels can help to lower this risk.\nSome studies have shown that drinking tomato juice can help to lower cholesterol levels. For example, a study published in the Journal of Nutrition found that drinking 100 ml of tomato juice per day for 12 weeks reduced LDL cholesterol levels by 12% in healthy adults. Another study published in the European Journal of Clinical Nutrition found that drinking 200 ml of tomato juice per day for 6 months reduced LDL cholesterol levels by 15% in people with high cholesterol.\nHowever, it's important to note that these studies were small and more research is needed to confirm these findings. Additionally, it's worth noting that tomato juice is not a magic bullet for lowering cholesterol levels, and it should be used in conjunction with other lifestyle changes, such as a healthy diet and regular exercise, to help manage cholesterol levels.\nIn summary, while there is some evidence to suggest that tomato juice may help lower cholesterol levels, more research is needed to confirm these findings and to determine the optimal dosage and duration of tomato juice consumption for cholesterol-lowering effects. As with any dietary intervention, it's important to consult with a healthcare professional before making significant changes to your diet."
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Hsp70 and Hsp110 are heat shock proteins that play a role in regulating mRNA stability by interacting with mRNAs and influencing their degradation. Hsp70 can bind to mRNAs and promote their degradation by the RNA exosome complex, while Hsp110 can also bind to mRNAs and inhibit their degradation by the RNA exosome. By modulating mRNA stability, these proteins can regulate gene expression in response to cellular stress."
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "Deiodinases are enzymes that play a crucial role in regulating the activity of thyroid hormones in various tissues, including skeletal muscle. There are three isoforms of deiodinases present in skeletal muscle:\n1. Deiodinase type 1 (D1): D1 is the primary deiodinase isoform in skeletal muscle, and it is responsible for converting T4 to T3. T3 is the active form of thyroid hormone that plays a crucial role in regulating muscle metabolism and growth.\n2. Deiodinase type 2 (D2): D2 is also present in skeletal muscle and plays a minor role in converting T4 to reverse T3 (rT3). rT3 is an inactive form of thyroid hormone that can inhibit the activity of T3.\n3. Deiodinase type 3 (D3): D3 is present in small amounts in skeletal muscle and plays a role in the regulation of thyroid hormone activity in the brain and other tissues.\nOverall, the balance between the activities of these deiodinases in skeletal muscle plays a critical role in regulating the activity of thyroid hormones and maintaining proper muscle function."
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Inflammatory caspase proteins are a group of proteins that play a role in the regulation of inflammation. Some examples of inflammatory caspase proteins include:\n1. Caspase-1: Also known as interleukin-1 beta (IL-1β) converter, this enzyme is involved in the processing and activation of pro-inflammatory cytokines, such as IL-1β and tumor necrosis factor-alpha (TNF-α).\n2. Caspase-4: Also known as interleukin-18 (IL-18) inducer, this enzyme is involved in the processing and activation of pro-inflammatory cytokines, such as IL-18.\n3. Caspase-5: Also known as cell death-associated protein 1 (CAD), this enzyme is involved in the regulation of programmed cell death (apoptosis) and inflammation.\n4. Caspase-6: Also known as apoptosis-related CPP32-like protein (ARC), this enzyme is involved in the regulation of programmed cell death (apoptosis) and inflammation.\n5. Caspase-7: Also known as apoptotic CPP32-like protein (APO-1), this enzyme is involved in the regulation of programmed cell death (apoptosis) and inflammation.\n6. Caspase-8: Also known as Fas-associated protein with death domain (FADD), this enzyme is involved in the regulation of programmed cell death (apoptosis) and inflammation, particularly in response to the death receptor Fas.\n7. Caspase-9: Also known as Bcl-2-associated death protein (BID), this enzyme is involved in the regulation of programmed cell death (apoptosis) and inflammation, particularly in response to the pro-apoptotic protein Bcl-2.\n8. Caspase-12: Also known as inflammasome-activating protein (IAP), this enzyme is involved in the regulation of inflammasome activation and the release of pro-inflammatory cytokines, such as inter"
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Yes, there is a link between Aurora B kinase and the Polycomb protein Ring1B. Ring1B is a component of the Polycomb repressive complex 2 (PRC2), which is involved in the epigenetic regulation of gene expression by modifying histone H3 lysine 27 (H3K27) into a repressive mark.\nAurora B kinase has been shown to interact with Ring1B and regulate its activity. Aurora B kinase phosphorylates Ring1B at specific sites, which can modulate its interaction with other proteins and impact its ability to recruit and activate the PRC2 complex.\nIn addition, Ring1B has been shown to play a role in the regulation of Aurora B kinase activity. For example, Ring1B can inhibit the activity of Aurora B kinase by binding to and sequestering its substrate, the histone H3.\nOverall, the interaction between Aurora B kinase and Ring1B is complex and multifaceted, and further research is needed to fully understand the mechanisms by which these proteins interact and impact each other's function."
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are sequences that are not part of the standard splice site consensus sequences, but are still recognized by the splicing machinery. Some of the most frequent non-canonical sequence motifs found in vertebrates include:\nDonor splice site motifs:\n* GU-rich sequences: GU-rich sequences are found in the intron and are recognized by the splicing machinery as a signal to initiate splicing.\n* AG-rich sequences: AG-rich sequences are found in the intron and are recognized by the splicing machinery as a signal to terminate splicing.\n* G/C-rich sequences: G/C-rich sequences are found in the intron and are recognized by the splicing machinery as a signal to initiate splicing.\n* A/T-rich sequences: A/T-rich sequences are found in the intron and are recognized by the splicing machinery as a signal to terminate splicing.\nAcceptor splice site motifs:\n* GU-rich sequences: GU-rich sequences are found in the acceptor splice site and are recognized by the splicing machinery as a signal to initiate splicing.\n* AG-rich sequences: AG-rich sequences are found in the acceptor splice site and are recognized by the splicing machinery as a signal to terminate splicing.\n* G/C-rich sequences: G/C-rich sequences are found in the acceptor splice site and are recognized by the splicing machinery as a signal to initiate splicing.\n* A/T-rich sequences: A/T-rich sequences are found in the acceptor splice site and are recognized by the splicing machinery as a signal to terminate splicing.\nIt's important to note that the frequency and distribution of these motifs can vary depending on the organism and the specific gene being studied. Additionally, some non-canonical motifs may be specific to certain types of splicing, such as alternative splicing or constitutive splicing."
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "The phosphorylation of S6K1 by Akt is an event that results in its acetylation."
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by mutations in the CACNA1A gene. The CACNA1A gene encodes a subunit of the calcium channel alpha-1A subunit, which is involved in the regulation of neuronal excitability and is critical for the proper functioning of the nervous system. Mutations in the CACNA1A gene lead to a decrease in the function of the calcium channel, resulting in the characteristic episodic ataxia symptoms."
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that add a methyl group to histone proteins, which can alter their interaction with DNA and affect chromatin structure and gene expression. While the specific functions of chromomethylases in animals are not as well understood as those in plants, there is evidence that they play important roles in regulating chromatin dynamics and gene expression in various organisms, including mammals. For example, some chromomethylases have been implicated in the regulation of gene expression during development, cell differentiation, and cellular stress responses. Additionally, alterations in chromomethylase activity have been linked to various diseases, including cancer and neurological disorders."
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "Here are some popular packages in R/Bioconductor for transcription factor binding site (TFBS) analysis:\n1. ChromHMM: This package uses a hidden Markov model (HMM) to predict TFBSs in DNA sequences. It can also be used to predict the binding affinity of TFs to their target sites.\n2. TFBS: This package provides a comprehensive set of tools for TFBS prediction, including the prediction of both protein-binding sites and the specificity of TFs.\n3. TRANSFAC: This package uses a Bayesian approach to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n4. Prodigal: This package predicts TFBSs in DNA sequences using a Bayesian approach and can also be used to predict the binding affinity of TFs to their target sites.\n5. GREAT: This package uses a Bayesian approach to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n6. HISAT2: This package uses a spliced aligner to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n7. STAR: This package uses a spliced aligner to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n8. DeepSEA: This package uses a deep learning approach to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n9. DeepBind: This package uses a deep learning approach to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\n10. ChromatinHMM: This package uses a HMM to predict TFBSs and can also be used to predict the binding affinity of TFs to their target sites.\nThese packages can be used to analyze TFBSs in various organisms, including humans, and can be used for a variety of applications, such as understanding gene regulation, predicting disease susceptibility, and identifying potential drug targets."
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "Here are some clinical trials related to the prevention of sarcopenia:\n1. \"Effects of Resistance Training on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics Society found that resistance training can help prevent sarcopenia in older adults.\n2. \"Exercise and Nutrition Interventions to Prevent Sarcopenia: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Medical Directors Association found that both exercise and nutrition interventions can help prevent sarcopenia in older adults.\n3. \"The Effects of Omega-3 Supplementation on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics Society found that omega-3 supplementation may help prevent sarcopenia in older adults.\n4. \"The Role of Vitamin D in the Prevention of Sarcopenia: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics Society found that vitamin D supplementation may help prevent sarcopenia in older adults.\n5. \"Effects of Resveratrol Supplementation on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics Society found that resveratrol supplementation may help prevent sarcopenia in older adults.\n6. \"The Effect of Tai Chi Exercise on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics Society found that tai chi exercise may help prevent sarcopenia in older adults.\n7. \"The Role of Probiotics in the Prevention of Sarcopenia: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Geriatrics"
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several databases of molecular recognition features in membrane proteins, including:\n1. The Membrane Protein Database (MPD): This database contains information on the structural and functional properties of membrane proteins, including their membrane-spanning domains, transmembrane helices, and binding sites for small molecules and other ligands.\n2. The Protein Data Bank (PDB): This database contains structural data on a wide range of proteins, including membrane proteins, and includes information on their three-dimensional structures, dynamics, and interactions with other molecules.\n3. The Membrane Protein Structural Alignment (MPSA): This database provides a collection of aligned structural models of membrane proteins, allowing for the comparison of different protein structures and the identification of conserved features and functional sites.\n4. The Membrane Protein Interaction Database (MPI): This database contains information on the interactions between membrane proteins and other molecules, including small molecules, peptides, and other proteins.\n5. The Membrane Protein Function Prediction (MPFP): This database provides predictive models of the functions of membrane proteins based on their structural and sequence data.\n6. The Membrane Protein-Ligand Interaction Database (MPI-LIB): This database contains information on the interactions between membrane proteins and ligands, including small molecules, peptides, and other proteins.\n7. The Membrane Protein-Protein Interaction Database (MPPI): This database contains information on the interactions between membrane proteins and other proteins, including protein-protein interactions that occur within the membrane or across the membrane.\n8. The Membrane Protein-Nucleic Acid Interaction Database (MPNA): This database contains information on the interactions between membrane proteins and nucleic acids, including DNA and RNA.\nThese databases provide valuable resources for studying the structure, function, and interactions of membrane proteins, and can be used to inform the design and development of therapeutic agents targeting these proteins."
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is metabolized by the liver and kidneys, with the liver being the primary site of metabolism. The kidneys play a secondary role in metabolizing rivaroxaban, with the enzyme uridine diphosphate glucuronosyltransferase (UGT) being responsible for glucuronidation of the drug. This metabolism helps to reduce the activity of rivaroxaban and increase its elimination from the body."
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TR alpha 2 regulates the expression of several genes in the heart, including:\n1. Atrial natriuretic factor (ANF): TR alpha 2 regulates the expression of ANF, a hormone that helps regulate blood pressure and fluid balance.\n2. Beta-myosin heavy chain (MHC-β): TR alpha 2 regulates the expression of MHC-β, a protein that plays a critical role in muscle contraction.\n3. Calmodulin (CaM): TR alpha 2 regulates the expression of CaM, a protein that helps regulate muscle contraction and relaxation.\n4. Cardiac troponin I (cTnI): TR alpha 2 regulates the expression of cTnI, a protein that plays a critical role in muscle contraction.\n5. GATA4: TR alpha 2 regulates the expression of GATA4, a transcription factor that plays a critical role in the development and maintenance of the cardiac conduction system.\n6. GATA6: TR alpha 2 regulates the expression of GATA6, a transcription factor that plays a critical role in the development and maintenance of the cardiac conduction system.\n7. Hypoxia-inducible factor (HIF) alpha: TR alpha 2 regulates the expression of HIF-α, a transcription factor that plays a critical role in response to hypoxia.\n8. Myosin-binding protein C (MYBPC): TR alpha 2 regulates the expression of MYBPC, a protein that plays a critical role in muscle contraction.\n9. Nuclear factor of kappa light chain enhancer in B cells 2 (NF-κB2): TR alpha 2 regulates the expression of NF-κB2, a transcription factor that plays a critical role in inflammation.\n10. Phospholamban (PLN): TR alpha 2 regulates the expression of PLN, a protein that plays a critical role in regulating calcium handling in the heart.\nThese genes are just a few examples of the many genes that are regulated by TR alpha 2 in the heart. The specific genes regulated by TR alpha 2 can vary depending on the cell type and the specific signaling pathway being studied."
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "Here are some of the available biomedical question answering systems:\n1. Biomedical Informatic Systems (BIS): BIS is a comprehensive database of biomedical question answering systems that provides a centralized platform for accessing and evaluating these systems.\n2. PubMedQA: PubMedQA is a biomedical question answering system that uses natural language processing techniques to answer questions based on the content of the PubMed database.\n3. BioASQ: BioASQ is a benchmarking platform for biomedical question answering systems that provides a collection of questions and a set of evaluation metrics to assess the performance of these systems.\n4. GeneAnswer: GeneAnswer is a gene-centric question answering system that uses natural language processing and machine learning techniques to answer questions about genes and gene functions.\n5. Med2RDF: Med2RDF is a biomedical question answering system that uses the Resource Description Framework (RDF) to represent biomedical knowledge and answer questions based on this knowledge.\n6. BioPortal: BioPortal is a biomedical question answering system that provides a range of tools for searching and analyzing biomedical literature, including a question answering functionality.\n7. Biomedical Question Answering System (BQAS): BQAS is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions based on a large corpus of biomedical text.\n8. BioQA: BioQA is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions based on a large corpus of biomedical text.\n9. MedQA: MedQA is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions based on the Medline database.\n10. Biomedical Text Mining (BTM): BTM is a biomedical question answering system that uses natural language processing and machine learning techniques to mine biomedical text and answer questions based on the extracted information.\nIt's worth noting that this is not an exhaustive list, and there are many other biomedical question answering systems available, each with its own strengths and weaknesses."
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "The transcription factor that activates the bethanechol pathway is NF-κB (Nuclear Factor Kappa B)."
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "There are several technologies that are commonly used for enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. These include:\n1. TiO2-based enrichment: This method uses titanium dioxide (TiO2) to selectively bind phosphorylated peptides based on their charge and hydrophilicity.\n2. IMAC (Immobilized Metal Affinity Chromatography): This method uses metal ions, such as copper or nickel, immobilized on a resin to bind phosphorylated peptides.\n3. Cation exchange (CE) chromatography: This method uses a cation exchange resin to separate phosphorylated peptides based on their charge.\n4. Hydrophilic interaction liquid chromatography (HILIC): This method uses a hydrophilic resin to separate phosphorylated peptides based on their hydrophilicity.\n5. Reversed-phase HPLC: This method uses a reversed-phase resin to separate phosphorylated peptides based on their hydrophobicity.\n6. Gel-based enrichment: This method uses a gel matrix to capture phosphorylated peptides based on their size and charge.\n7. Microfluidic-based enrichment: This method uses microfluidic devices to capture phosphorylated peptides based on their size and charge.\n8. Nanoscale enrichment: This method uses nanoscale materials, such as nanoparticles or nanotubes, to capture phosphorylated peptides based on their size and charge.\n9. Protein G-based enrichment: This method uses protein G to bind phosphorylated peptides based on their phosphorylation state.\n10. Magnetic nanoparticle-based enrichment: This method uses magnetic nanoparticles to capture phosphorylated peptides based on their charge and hydrophilicity.\nIt's worth noting that each technology has its own advantages and disadvantages, and the choice of technology will depend on the specific research question and experimental design."
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "Palmini classification is used to rate the severity of intellectual disability. It is a system used to classify intellectual disability based on the severity of cognitive and adaptive functioning deficits."
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, some viruses have been implicated in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition of the thyroid gland that can occur in response to various triggers, including viral infections.\nSome viruses that have been linked to the development of subacute thyroiditis include:\n1. Viruses that affect the thyroid gland directly:\nSome viruses, such as the thyroid gland-specific virus (TGSV), have been shown to directly infect the thyroid gland and cause inflammation. TGSV is a member of the parvovirus family and is the most common virus to infect the thyroid gland.\n2. Viruses that affect the immune system:\nViruses that affect the immune system, such as Epstein-Barr virus (EBV), can also contribute to the development of subacute thyroiditis. EBV is a common herpesvirus that is known to cause infectious mononucleosis and has been linked to various autoimmune diseases, including subacute thyroiditis.\n3. Viruses that are transmitted through blood transfusions:\nIn rare cases, subacute thyroiditis can be caused by viruses that are transmitted through blood transfusions. For example, a study published in the New England Journal of Medicine in 2009 found that some cases of subacute thyroiditis were linked to exposure to the hepatitis B virus through blood transfusions.\nIt's important to note that the exact mechanisms by which viruses contribute to the development of subacute thyroiditis are not yet fully understood and may involve complex interactions between the virus, the immune system, and the thyroid gland. Further research is needed to determine the exact role of viruses in the etiology of this condition."
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2 (also known as eukaryotic translation initiation factor 2-alpha kinase 2) is a kinase that phosphorylates and inhibits the translation initiation factor eIF2α, leading to suppression of global protein synthesis and induction of autophagy. STAT3 (Signal Transducer and Activator of Transcription 3) is a transcription factor that is involved in the regulation of various cellular processes, including inflammation and autophagy. Studies have shown that STAT3 is activated downstream of EIF2AK2 and plays a role in the regulation of EIF2AK2-dependent autophagy suppression. Specifically, STAT3 phosphorylation is required for the maintenance of autophagy suppression and the prevention of cell death during EIF2AK2-mediated autophagy suppression."
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theatre is a software tool used for genomic analysis, specifically for the analysis of chromatin structure and epigenetic marks. It was developed by the lab of Eric Davidson at the University of California, San Francisco.\nTheatre is designed to analyze the spatial organization of chromatin and epigenetic marks at the level of individual cells, allowing researchers to gain insights into the regulatory mechanisms that control gene expression. The tool can be used to analyze a variety of genomic data types, including:\n1. ChIP-seq data: Theatre can be used to identify regions of the genome that are bound by specific transcription factors or other proteins, and to understand the spatial organization of these binding events.\n2. DNA methylation data: Theatre can be used to identify regions of the genome that are methylated or unmethylated, and to understand the spatial organization of these marks.\n3. Histone modification data: Theatre can be used to identify regions of the genome that are modified by specific histone modifications, such as histone 3 lysine 4 trimethylation (H3K4me3) or histone 3 lysine 27 trimethylation (H3K27me3), and to understand the spatial organization of these marks.\n4. RNA sequencing data: Theatre can be used to identify regions of the genome that are actively transcribed, and to understand the spatial organization of gene expression.\nThe usage of Theatre software tool for genomic analysis includes:\n1. Identifying regions of the genome that are bound by specific transcription factors or other proteins.\n2. Understanding the spatial organization of chromatin structure and epigenetic marks.\n3. Identifying regions of the genome that are actively transcribed.\n4. Analyzing the regulatory mechanisms that control gene expression.\n5. Identifying the interactions between different regulatory elements and their target genes.\n6. Understanding the role of chromatin structure and epigenetic marks in gene regulation.\n7. Identifying the differences in chromatin structure and epigenetic marks between different cell types or tissues.\n8. Analyzing the effects of different stimuli or drugs on chromatin structure and epigenetic marks.\n9. Identifying the regulatory elements that are responsible for the specific gene expression patterns.\n10"
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), where n is the length of the shorter sequence. This is because the algorithm compares each element of the shorter sequence with every element of the longer sequence, resulting in a total of n^2 comparisons."
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the solute carrier (SLC) family of transport proteins. Specifically, it is a member of the SLC12 family, which is also known as the hydroxyl-carboxylate carrier family."
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1 is a transcription factor that plays a crucial role in regulating gene expression in various cell types, including hematopoietic cells. The biotinylation tagging approach has been used to identify GATA-1 interacting partners in various studies. Here are some of the GATA-1 interacting partners that have been identified using this approach:\n1. HDAC1: GATA-1 was shown to interact with histone deacetylase 1 (HDAC1) in a study published in the journal Nature in 2003.\n2. p300: GATA-1 was found to interact with the histone acetyltransferase p300 in a study published in the journal Cell in 2007.\n3. CBF1: GATA-1 was shown to interact with the transcription factor CBF1 in a study published in the journal Cell in 2010.\n4. KAT2A: GATA-1 was found to interact with the lysine acetyltransferase KAT2A in a study published in the journal Nature Communications in 2017.\n5. RBBP4: GATA-1 was shown to interact with the RNA-binding protein RBBP4 in a study published in the journal Nature Structural & Molecular Biology in 2018.\n6. H3K27ac: GATA-1 was found to interact with histone H3 lysine 27 acetyltransferase (H3K27ac) in a study published in the journal Nature Communications in 2019.\n7. TFIIA: GATA-1 was shown to interact with the transcription factor IIA (TFIIA) in a study published in the journal Cell Reports in 2020.\nThese studies demonstrate that GATA-1 interacts with a variety of proteins involved in transcriptional regulation, chromatin modification, and RNA processing, highlighting the complexity of GATA-1's regulatory network."
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "TAF10 interacts with the GATA1 transcription factor to facilitate the recruitment of RNA polymerase II (RNAPII) to the promoter region of target genes and to modulate the activity of GATA1 in regulating gene expression."
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) available for chronic pain management. A DSS is a computer-based system that provides healthcare professionals with clinical decision-making support by analyzing patient data and providing recommendations for diagnosis, treatment, and management of chronic pain. Here are some examples of DSS for chronic pain management:\n1. Chronic Pain Management Decision Support System (CPM-DSS): This system was developed by the University of Washington and provides a comprehensive framework for managing chronic pain. It includes clinical decision rules, clinical practice guidelines, and a knowledge base of pain management strategies.\n2. PainCare: This DSS was developed by the University of California, Los Angeles (UCLA) and provides a comprehensive approach to chronic pain management. It includes a pain assessment tool, treatment recommendations, and a database of pain management strategies.\n3. PainPathways: This DSS was developed by the University of Washington and provides a comprehensive framework for managing chronic pain. It includes clinical decision rules, clinical practice guidelines, and a knowledge base of pain management strategies.\n4. Chronic Pain Management System (CPMS): This system was developed by the University of California, San Francisco (UCSF) and provides a comprehensive approach to chronic pain management. It includes a pain assessment tool, treatment recommendations, and a database of pain management strategies.\n5. Pain-Q: This DSS was developed by the University of California, San Diego (UCSD) and provides a comprehensive approach to chronic pain management. It includes a pain assessment tool, treatment recommendations, and a database of pain management strategies.\n6. Pain Management Decision Support System (PMDSS): This system was developed by the University of Texas Health Science Center at Houston and provides a comprehensive framework for managing chronic pain. It includes clinical decision rules, clinical practice guidelines, and a knowledge base of pain management strategies.\n7. Chronic Pain Management Toolkit (CPMT): This system was developed by the University of Florida and provides a comprehensive approach to chronic pain management. It includes a pain assessment tool, treatment recommendations, and a database of pain management strategies.\n8. Pain Management and Research Network (PMRN):"
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a secreted protein that localizes to the cytoplasm and nucleus of cells."
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine does not directly affect kinase signaling activation in the heart. Its primary mechanism of action is to inhibit the activity of the enzyme ATP-sensitive potassium (KATP) channels, which are involved in the regulation of cardiac ion homeostasis and excitation-contraction coupling in the heart. By inhibiting KATP channels, ranolazine reduces the influx of potassium ions into the cardiac myocyte, leading to a decrease in the duration of the action potential and a decrease in the force of contraction. This can be beneficial in treating certain heart conditions, such as angina pectoris, where the heart muscle is not receiving enough oxygen due to reduced blood flow."
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "No, the regulation of Vsr endonuclease is not independent of the growth phase of bacteria. Vsr endonuclease activity is positively regulated during the stationary phase of bacterial growth, when the cell is under stress and needs to repair DNA damage. In this phase, the expression of the gene encoding Vsr endonuclease is upregulated, leading to increased enzyme activity and the degradation of DNA damage."
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several computational tools that can be used for the prediction of beta-barrel transmembrane proteins. Some of the commonly used tools include:\n1. BepiPred: BepiPred is a web server that uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains in proteins. It uses a machine learning algorithm to classify amino acid residues into different types based on their hydrophobicity and other features.\n2. TMHMM: TMHMM is a widely used tool for predicting transmembrane helices in proteins. It uses a combination of sequence analysis and structure-based methods to predict the presence of transmembrane helices and their orientation in the membrane.\n3. PredictProtein: PredictProtein is a web server that can be used to predict the structure and function of proteins. It includes tools for predicting transmembrane helices, and it uses a combination of sequence analysis and structure-based methods to make its predictions.\n4. SignalP: SignalP is a tool for predicting the presence of signal peptides in proteins. While it does not specifically predict beta-barrel transmembrane proteins, it can be used in combination with other tools to identify potential membrane proteins.\n5. Membrane Protein Structure Prediction (MPSP): MPSP is a web server that can be used to predict the three-dimensional structure of beta-barrel transmembrane proteins. It uses a combination of sequence analysis and structure-based methods to make its predictions.\n6. PHD-TOPO: PHD-TOPO is a tool for predicting the topology of transmembrane proteins. It uses a combination of sequence analysis and structure-based methods to predict the arrangement of transmembrane helices in the membrane.\n7. TM-align: TM-align is a tool for aligning multiple transmembrane protein structures. It can be used to identify conserved regions in beta-barrel transmembrane proteins and to predict their structure.\n8. TM-pred: TM-pred is a tool for predicting the presence and orientation of transmembrane helices in proteins. It uses a combination of sequence analysis and structure-based methods to make its predictions.\n9. Transmembrane Helix"
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "Galassi classification is used to classify developmental disorders, specifically those related to chromosomal abnormalities."
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "Shapiro syndrome, also known as Shapiro-Olivecrona syndrome, is a rare genetic disorder that affects the development of the nervous system and other systems in the body. Here are some common features of Shapiro syndrome:\n1. Neurological problems: The most common feature of Shapiro syndrome is neurological problems, which can include seizures, intellectual disability, and movement disorders such as ataxia and chorea.\n2. Distinctive facial features: People with Shapiro syndrome may have distinctive facial features, including a small head, narrow eyes, and a short nose.\n3. Growth delays: Children with Shapiro syndrome may experience growth delays, both in terms of height and weight.\n4. Skeletal abnormalities: Shapiro syndrome can cause a range of skeletal abnormalities, including joint contractures, scoliosis, and other skeletal deformities.\n5. Developmental delays: Children with Shapiro syndrome may experience delays in reaching developmental milestones, such as sitting, standing, and walking.\n6. Vision problems: Some people with Shapiro syndrome may experience vision problems, including cataracts, glaucoma, and other eye disorders.\n7. Hearing loss: Hearing loss is a common feature of Shapiro syndrome, and can range from mild to profound.\n8. Respiratory problems: Shapiro syndrome can cause a range of respiratory problems, including respiratory infections, sleep apnea, and other breathing difficulties.\n9. Cardiovascular problems: Some people with Shapiro syndrome may experience cardiovascular problems, including heart defects and abnormal heart rhythms.\n10. Increased risk of infections: People with Shapiro syndrome may be at increased risk of infections, particularly respiratory infections, due to their immune system dysfunction.\nIt's important to note that the severity of Shapiro syndrome can vary widely between individuals, and not all individuals will experience all of these features. If you have concerns about your child's health, it's important to consult with a"
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 (BRAG-1-related gene 1) is associated with Charcot-Marie-Tooth disease (CMT), a group of inherited disorders that affect the peripheral nervous system. Mutations in the BRAG1 gene have been identified as a cause of some forms of CMT."
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "The main inhibitor of protein phosphatase 1 (PP1) is called protein phosphatase 1 inhibitor 1 (PP1I1)."
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, in Bacillus subtilis involves the mutation of genes in response to environmental stress, particularly during stationary phase. There are several mechanisms that underlie this process:\n1. DNA damage response: DNA damage can occur during stationary phase due to various factors, including the accumulation of reactive oxygen species (ROS) and the degradation of DNA repair machinery. In response to this damage, the cell activates the DNA damage response, which can lead to the mutation of nearby genes.\n2. Genomic rearrangements: During stationary phase, the cell can undergo genome rearrangements, such as gene deletions, duplications, and translocations. These events can result in the mutation of genes and lead to the adaptation of the organism to the stressful environment.\n3. RNA-mediated mutagenesis: RNA molecules, such as small RNAs and non-coding RNAs, can base-pair with specific DNA sequences and induce mutations through mechanisms such as RNA-guided DNA methylation or RNA-induced genetic silencing.\n4. Horizontal gene transfer: During stationary phase, bacteria can exchange genetic material with other cells, leading to the acquisition of new genes and mutations. This process, known as horizontal gene transfer, can provide the cell with new genetic material that can help it adapt to the stressful environment.\n5. Mutator phenotype: Some mutations can lead to a mutator phenotype, where the cell becomes more prone to mutations due to defects in DNA repair machinery. This can result in an increased ability to adapt to stressful environments through the accumulation of beneficial mutations.\nIn summary, adaptive mutagenesis in Bacillus subtilis involves a complex interplay of different mechanisms, including DNA damage response, genomic rearrangements, RNA-mediated mutagenesis, horizontal gene transfer, and mutator phenotype. These mechanisms allow the cell to adapt to stressful environments and survive in a changing environment."
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erucism, also known as erythrocytosis, is a condition characterized by an increase in the number of red blood cells (RBCs) in the blood. There are several possible causes of erucism, including:\n1. Genetic disorders: Some genetic disorders, such as polycythemia vera, can cause erucism.\n2. Chronic hypoxia: Prolonged exposure to low oxygen levels can stimulate the production of RBCs.\n3. Chronic inflammation: Inflammation can lead to the production of erythropoietin (EPO), a hormone that stimulates the production of RBCs.\n4. Cancer: Some types of cancer, such as kidney cancer, can cause erucism by producing EPO.\n5. Other medical conditions: Certain medical conditions, such as hypothyroidism and anemia, can also cause erucism.\n6. Medications: Certain medications, such as anabolic steroids, can increase the production of RBCs.\n7. Infections: Some infections, such as malaria, can cause erucism by stimulating the production of RBCs.\n8. Nutritional deficiencies: Deficiencies in iron, folate, and vitamin B12 can lead to erucism.\n9. Chronic fatigue syndrome: Some studies suggest that erucism may be a feature of chronic fatigue syndrome.\n10. Other factors: Other factors that may contribute to erucism include chronic stress, sleep disorders, and exposure to toxins.\nIt is important to note that the exact cause of erucism in an individual may depend on the underlying medical condition or disorder. A healthcare professional can help determine the underlying cause of erucism and develop an appropriate treatment plan."
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide (HCTZ) is a diuretic medication that is commonly used to treat a variety of conditions, including:\n1. Hypertension (high blood pressure): HCTZ is used to lower blood pressure in patients with mild to moderate hypertension.\n2. Heart failure: HCTZ can help reduce fluid buildup and improve symptoms in patients with heart failure.\n3. Edema (swelling): HCTZ is used to treat edema (swelling) caused by fluid buildup in the body, which can occur due to various conditions such as liver disease, kidney disease, or cancer.\n4. Nephrotic syndrome: HCTZ can help reduce the amount of protein lost in the urine in patients with nephrotic syndrome, a condition characterized by excessive protein loss in the urine.\n5. Diabetic nephropathy: HCTZ can help slow the progression of diabetic nephropathy, a complication of diabetes that can lead to kidney damage and failure.\n6. Renal tubular acidosis: HCTZ can help correct the acid-base balance in the body by increasing the excretion of hydrogen ions in the urine.\n7. Cystinuria: HCTZ can help reduce the amount of cystine in the urine in patients with cystinuria, a condition that causes cystine to be excreted in the urine.\n8. Hyperaldosteronism: HCTZ can help reduce the amount of aldosterone in the body, which can help treat conditions such as primary aldosteronism and secondary aldosteronism.\n9. Hypokalemia: HCTZ can help increase potassium levels in the body, which can help treat hypokalemia (low potassium levels).\n10. Other conditions: HCTZ may also be used to treat other conditions such as migraines, urticaria, and angioedema.\nIt is important to note that HCTZ may have different indications and contraindications in different countries and regions, and it is always best to consult with a healthcare professional for specific information and advice."
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Yes, silicon has been used in the treatment of incontinence. Silicon-based materials have been developed and used in various applications, including:\n1. Urinary incontinence: Silicon-based materials have been used to create devices that can help to strengthen the muscles in the pelvic floor, which can help to improve bladder control and reduce the risk of incontinence.\n2. Prostate surgery: Silicon-based materials have been used to create devices that can help to reduce the risk of complications during prostate surgery, such as urinary incontinence.\n3. Wound healing: Silicon-based materials have been used to create devices that can help to promote wound healing and reduce the risk of infection.\n4. Bone grafting: Silicon-based materials have been used to create devices that can help to promote bone growth and healing in the treatment of bone fractures and other bone disorders.\n5. Drug delivery: Silicon-based materials have been used to create devices that can help to deliver drugs in a targeted and controlled manner, which can help to improve the effectiveness of treatments and reduce the risk of side effects.\n6. Cancer treatment: Silicon-based materials have been used to create devices that can help to deliver drugs directly to cancer cells, which can help to improve the effectiveness of treatments and reduce the risk of side effects.\n7. Neurological disorders: Silicon-based materials have been used to create devices that can help to treat neurological disorders, such as epilepsy and Parkinson's disease.\n8. Cardiovascular disease: Silicon-based materials have been used to create devices that can help to treat cardiovascular disease, such as heart failure and atherosclerosis.\n9. Ophthalmic disorders: Silicon-based materials have been used to create devices that can help to treat ophthalmic disorders, such as cataracts and glaucoma.\n10. Orthopedic disorders: Silicon-based materials have been used to create devices that can help to treat orthopedic disorders, such as osteoarthritis and fractures.\nIt is important to note that the use of silicon-"
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "There is a potential association between the moon cycle and the rupture risk of intracranial aneurysms. Some studies have suggested that the incidence of rupture of intracranial aneurysms may be higher during the full moon than during other times of the month. This phenomenon has been observed in several studies, including a 2017 meta-analysis of 14 observational studies that found a significant association between the full moon and rupture of intracranial aneurysms.\nThe exact mechanism behind this association is not fully understood, but several theories have been proposed. One theory is that the increased blood pressure during the full moon, caused by the gravitational pull of the moon, may increase the pressure within an intracranial aneurysm and increase the likelihood of rupture. Another theory is that the changes in blood flow and vessel diameter that occur during the full moon may affect the stability of the aneurysm wall and increase the risk of rupture.\nIt is important to note that the association between the moon cycle and rupture risk of intracranial aneurysms is still a topic of debate, and more research is needed to confirm these findings and to understand the underlying mechanisms. Additionally, it is important to note that the risk of rupture of an intracranial aneurysm is not directly related to the moon cycle, and other factors such as the size and location of the aneurysm, as well as the patient's age and medical history, are much more important in determining the risk of rupture."
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "No, HuR protein does not directly regulate the splicing process. HuR (also known as ELAVL1) is a protein that is involved in the regulation of mRNA stability and translation, but it does not play a role in the splicing process. Splicing is the process by which introns (non-coding regions) are removed from pre-mRNA and exons (coding regions) are joined together to form mature mRNA. HuR protein is involved in the regulation of mRNA stability and translation by binding to specific sequences in the 3' untranslated region (UTR) of target mRNAs and preventing their degradation."
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "Prothymosin alpha (ProT) is a small protein that plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival. The c-terminal peptide of ProT, also known as ProT-CT, has been shown to have several distinct functions:\n1. Cell cycle regulation: ProT-CT can inhibit the activity of cyclin-dependent kinases (CDKs), which are key regulators of the cell cycle, thereby arresting the cell cycle at the G1/S transition.\n2. Apoptosis: ProT-CT has been shown to inhibit the induction of apoptosis by various pro-apoptotic factors, such as Bax and Bak, and can protect cells against chemotherapy-induced apoptosis.\n3. DNA damage response: ProT-CT can repair DNA double-strand breaks by interacting with the Ku70/80 complex and promoting the assembly of the DNA repair machinery.\n4. Nuclear factor kappa B (NF-κB) activation: ProT-CT can inhibit the activation of NF-κB, a transcription factor that regulates the expression of genes involved in inflammation and immune response.\n5. Autophagy: ProT-CT has been shown to inhibit autophagy, a cellular process that helps to maintain cellular homeostasis by degrading damaged or dysfunctional cellular components.\n6. Stem cell maintenance: ProT-CT has been shown to promote the maintenance of stem cells by inhibiting the differentiation of stem cells and promoting their proliferation.\n7. Tumor suppressor activity: ProT-CT has been shown to have tumor suppressor activity in various cancer models, and it is thought to play a role in the regulation of cellular processes that are involved in cancer development and progression.\nIn summary, ProT-CT has a wide range of functions in the cell, including cell cycle regulation, apoptosis, DNA damage response, NF-κB activation, autophagy, stem cell maintenance, and tumor suppressor activity."
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the amino acid sequence RRQARRR."
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "Yes, the concentration of protein HIF-1α increases after the administration of the cytoprotective prodrug ethyol (amifostine). Ethyol is a prodrug that is converted into the active compound amifostine, which has been shown to increase the expression of hypoxia-inducible factor 1 alpha (HIF-1α) in various cell types, including cancer cells. HIF-1α is a transcription factor that plays a critical role in response to hypoxia and is involved in the regulation of various cellular processes, including angiogenesis, glucose metabolism, and cell survival."
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 is a histone methyltransferase that deposits histone H3 lysine 4 trimethylation (H3K4me3) marks on histone H3."
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "Hepcidin is a protein that is involved in the regulation of iron metabolism, and it has 4 disulfide bridges."
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene DNAJC11 is localized to the mitochondria."
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs). CNVs are genomic regions that are duplicated or deleted in a copy number manner, and they often involve genes that are important for various biological processes. UCEs, on the other hand, are short, highly conserved sequences that are found throughout the genome and are thought to be involved in regulating gene expression.\nStudies have shown that UCEs are enriched in regions of the genome that are not affected by CNVs, suggesting that these elements are less likely to be disrupted by copy number changes. In fact, one study found that UCEs were depleted among CNVs in a sample of individuals with intellectual disability, suggesting that these elements may be particularly important for maintaining genome stability.\nThe reason why UCEs are depleted among CNVs is not fully understood, but it is thought to be related to the fact that UCEs are often located in regions of the genome that are highly conserved across species, and that CNVs are more likely to occur in regions that are less conserved. Additionally, UCEs may be more sensitive to changes in copy number due to their high conservation, which could make them more prone to disruption by CNVs.\nOverall, the depletion of UCEs among CNVs suggests that these elements play a critical role in maintaining genome stability and that their disruption may have important consequences for human health."
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "Has2 (Haspin) is a kinase that plays a crucial role in the regulation of mitotic progression. The substrate of Has2 during mitosis is the protein Kinase A (PKA). Has2 phosphorylates and activates PKA, which in turn regulates various cellular processes during mitosis, including the progression from G2/M phase to M phase."
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroid replication is a unique mechanism of replication that does not involve the synthesis of new DNA or RNA. Instead, viroids replicate by recombination, a process in which the viroid molecule is broken and then reassembled into a new molecule. This process occurs through a mechanism that is not yet fully understood and is thought to involve the interaction of viroids with host cell factors."
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Fibronectin is not a commonly used serum biomarker for Duchenne muscular dystrophy (DMD). While fibronectin is a protein that is involved in various cellular processes, including cell adhesion and migration, its levels in the blood are not typically used as a diagnostic marker for DMD.\nThere are several established serum biomarkers for DMD, including:\n1. Dystrophin: The lack of dystrophin protein in the muscles of individuals with DMD is a hallmark of the disease. Measuring the levels of dystrophin in the blood can help diagnose DMD and monitor the progression of the disease.\n2. CK: Creatine kinase (CK) is an enzyme that is involved in muscle metabolism. Elevated levels of CK in the blood can indicate muscle damage or disease, including DMD.\n3. CK-MB: Creatine kinase-MB (CK-MB) is a specific isoform of CK that is primarily found in the heart. Elevated levels of CK-MB in the blood can indicate muscle damage or disease, including DMD.\n4. Lactate dehydrogenase (LDH): LDH is an enzyme that is involved in muscle metabolism. Elevated levels of LDH in the blood can indicate muscle damage or disease, including DMD.\n5. Aldolase: Aldolase is an enzyme that is involved in glycolysis. Elevated levels of aldolase in the blood can indicate muscle damage or disease, including DMD.\nIt is important to note that these biomarkers are not specific to DMD and can be elevated in other muscle disorders or conditions. Therefore, a comprehensive diagnostic evaluation, including clinical evaluation, imaging studies, and genetic testing, is necessary for accurate diagnosis and management of DMD."
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. The ENCODE (ENCyclopedia Of DNA Elements) Project: This project is a large-scale effort to map all of the functional elements in the human genome.\n2. The Roadmap Epigenomics Project: This project aims to create a comprehensive map of the epigenetic marks on the human genome and their functional implications.\n3. The Epigenome-wide Association Study (EWAS) Project: This project involves scanning the entire genome for epigenetic marks that are associated with specific diseases or traits.\n4. The Human Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the human genome and their functional implications.\n5. The Mouse Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the mouse genome and their functional implications.\n6. The Arabidopsis Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the Arabidopsis thaliana genome and their functional implications.\n7. The Yeast Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the Saccharomyces cerevisiae genome and their functional implications.\n8. The Drosophila Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the Drosophila melanogaster genome and their functional implications.\n9. The Zebrafish Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the Danio rerio genome and their functional implications.\n10. The Human Placenta Epigenome Project: This project aims to create a comprehensive map of the epigenetic marks on the human placenta and their functional implications.\nThese projects have generated a large amount of data on the epigenetic marks present in various organisms, including their distribution, distribution, and functional implications. The data from these projects are stored in the DeepBlue epigenomic data server and are available for researchers to access and analyze."
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "The tool that employs self-organizing maps for analyzing synonymous codon usage is called \"CodonVar.\""
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 (Microtubule-Associated Protein 1 light chain 1, also known as EB1) is a protein that plays a crucial role in the regulation of microtubule dynamics and cellular behavior. It is a plus-end tracking protein that binds to the plus ends of microtubules and helps to maintain their stability and organization. MINDY-1 has been implicated in various cellular processes, including cell division, intracellular transport, and cell signaling. It is also a potential therapeutic target for various diseases, including cancer and neurodegenerative disorders."
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "There are several software packages available for the analysis of conserved genomic loci, including:\n1. PhyloBayes: A Bayesian phylogenetic software package for inferring the evolutionary history of genomic regions.\n2. PhastCons: A program for inferring conserved non-coding sequences in a genome.\n3. GERP: A program for identifying conserved genomic regions based on a hidden Markov model.\n4. ConServ: A tool for identifying conserved genomic regions and predicting their functional implications.\n5. Prodigal: A program for predicting conserved non-coding RNA elements in a genome.\n6. CNS: A tool for identifying conserved non-coding RNA elements in a genome.\n7. PANTHER: A program for identifying conserved non-coding RNA elements and predicting their functional implications.\n8. HMMER: A program for identifying conserved genomic regions using a hidden Markov model.\n9. MUSCLE: A multiple sequence alignment tool that can be used to identify conserved genomic regions.\n10. MAFFT: A multiple sequence alignment tool that can be used to identify conserved genomic regions.\nThese software packages can be used to identify and analyze conserved genomic loci, and to predict their functional implications."
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "The PIEZO2 gene has been associated with several diseases, including:\n1. Hypertension: Mutations in the PIEZO2 gene have been identified as a cause of hypertension, a condition characterized by high blood pressure.\n2. Nephrocalcinosis: PIEZO2 mutations can lead to an accumulation of calcium in the kidneys, a condition known as nephrocalcinosis, which can cause kidney damage and disease.\n3. Kidney disease: PIEZO2 mutations have been linked to various kidney diseases, including chronic kidney disease and end-stage renal disease.\nPlease note that this is not an exhaustive list, and PIEZO2 mutations may be associated with other diseases as well."
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the efficient processing of double-stranded RNA (dsRNA) to small interfering RNA (siRNA) and microRNA (miRNA), which are important for RNA interference (RNAi) and the regulation of gene expression."
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are both involved in the regulation of BMP signaling, which is important for the proper development and maintenance of the gallbladder. In non-damaged gallbladders, R-spondin 1 and Noggin work together to regulate the proliferation and differentiation of gallbladder epithelial cells, and to maintain the proper structure and function of the gallbladder. Specifically, R-spondin 1 promotes the proliferation of gallbladder epithelial cells, while Noggin inhibits their differentiation. This balance of R-spondin 1 and Noggin activity is important for the proper maintenance of the gallbladder and its ability to store and release bile in response to nutrient availability."
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "Yes, NADPH oxidase 5 (NOX5) requires a subunit called p47phox for its function. p47phox is a crucial subunit that forms the catalytic core of NOX5 and is necessary for the enzyme's activity."
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are connected in the regulation of iron metabolism. Furin is a protease that cleaves the precursor form of hepcidin, a hormone produced in the liver that regulates iron absorption and distribution in the body. The cleavage of hepcidin by furin leads to its activation and the subsequent inhibition of iron absorption in the duodenum and the release of iron from stores in the liver. This connection helps to regulate iron homeostasis in the body and prevent iron overload."
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, which is composed of 16 genes involved in the breakdown of glucose to produce energy."
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "The role of LMT lncRNA (Loss of Heterozygosity in Microcephaly and Brain Tumors) is not well understood, as it is a recently identified lncRNA and there is limited research available on its function. However, studies have suggested that LMT lncRNA may play a role in the regulation of gene expression, particularly in the context of brain development and cancer.\nOne study found that LMT lncRNA is overexpressed in certain types of brain tumors, and that its expression is associated with poor prognosis. Another study found that LMT lncRNA regulates the expression of genes involved in cellular processes such as cell division and differentiation.\nOverall, while the exact role of LMT lncRNA is still being studied, it is clear that it plays an important role in the regulation of gene expression and may be involved in the development and progression of certain diseases, including brain tumors."
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "There are several R packages and bioconductor packages that can be used for performing SNP (Single Nucleotide Polymorphism) enrichment analysis. Some of the commonly used packages include:\n1. `SNPset`: This package provides a comprehensive set of tools for SNP analysis, including enrichment analysis. It uses a Bayesian approach to detect overrepresented SNPs in a given dataset.\n2. `SNP_Enrichment`: This package provides a variety of tools for SNP enrichment analysis, including a non-parametric test for detecting overrepresented SNPs.\n3. `GSEA`: This package (GSEA = Gene Set Enrichment Analysis) is a popular tool for identifying gene sets that are overrepresented in a given dataset. It can be used for SNP enrichment analysis by comparing the genes near the SNPs to a predefined set of gene sets.\n4. `Pathway Studio`: This package provides a comprehensive set of tools for pathway analysis, including enrichment analysis. It can be used to identify overrepresented pathways in a given dataset of SNPs.\n5. `Plink`: This package is a popular tool for genome-wide association studies (GWAS) and can be used for SNP enrichment analysis by comparing the genotype frequencies of the SNPs in the dataset to a reference panel.\nThese are just a few examples of the many R packages and bioconductor packages available for SNP enrichment analysis. The choice of package will depend on the specific requirements of the analysis and the nature of the dataset being analyzed."
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "Radial glial cells are specified to become ependymal cells through a complex interplay of signaling pathways and molecular mechanisms. The key players involved in this process include:\n1. Notch signaling: Notch is a critical regulator of radial glial cell fate and is essential for the specification of radial glial cells to ependymal cells. Notch signaling promotes the expression of ependymal-specific genes and regulates the expression of genes involved in the maintenance of radial glial cell identity.\n2. Wnt signaling: Wnt signaling also plays a crucial role in regulating the specification of radial glial cells to ependymal cells. Wnt signaling promotes the expression of genes involved in the maintenance of ependymal cell identity and regulates the expression of genes involved in the specification of radial glial cells.\n3. BMP signaling: BMP signaling is also involved in the specification of radial glial cells to ependymal cells. BMP signaling promotes the expression of genes involved in the maintenance of ependymal cell identity and regulates the expression of genes involved in the specification of radial glial cells.\n4. Shh signaling: Shh signaling is also involved in the specification of radial glial cells to ependymal cells. Shh signaling regulates the expression of genes involved in the maintenance of ependymal cell identity and promotes the expression of genes involved in the specification of radial glial cells.\n5. EGFR signaling: EGFR signaling is also involved in the specification of radial glial cells to ependymal cells. EGFR signaling promotes the expression of genes involved in the maintenance of ependymal cell identity and regulates the expression of genes involved in the specification of radial glial cells.\n6. FGF signaling: FGF signaling is also involved in the specification of radial glial cells to ependymal cells. FGF signaling promotes the expression of genes involved in the maintenance of ependymal cell identity and regulates the expression of genes involved in the specification of radial glial cells.\n7. Sox2: Sox2 is a transcription factor that is essential for the maintenance of radial glial cell identity and the specification of radial glial cells to ep"
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are a type of glioma that lack expression of the tumor suppressor proteins P53, EGFR, and MIB1. These proteins are commonly targeted by chemotherapy and are used as markers for diagnosis and prognosis in glioma. Triple negative gliomas are aggressive and tend to have a poorer prognosis compared to gliomas that express these proteins. They are often associated with a higher risk of recurrence and are more likely to be resistant to chemotherapy and radiation therapy."
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 (Topoisomerase II-associated protein A1) is a protein that is involved in the regulation of DNA topology and chromosome segregation during cell division. It is a component of the spindle assembly checkpoint, which ensures proper chromosome alignment and separation during mitosis. TOPAZ1 is a protein that interacts with topoisomerase II and other proteins to regulate the relaxation of DNA supercoils and the formation of the spindle fibers that separate chromosomes during cell division."
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "The expression of GATA-1 isoforms is controlled by the GATA-1 gene."
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a sequencing-based method used to identify and quantify miRNAs (microRNAs) in a sample. MIRA-seq stands for \"MicroRNA Identification and Quantification by Sequencing.\" It is a next-generation sequencing (NGS) technology that allows for the simultaneous analysis of thousands of miRNAs in a single run, providing a comprehensive picture of the miRNA landscape in a given sample.\nThe MIRA-seq protocol typically involves the following steps:\n1. Sample preparation: The sample is first prepared by isolating the RNA from the cells or tissue of interest.\n2. Library preparation: The RNA is then converted into a sequencing library using a series of enzymatic reactions and chemical modifications.\n3. Sequencing: The sequencing library is then loaded onto a sequencing machine, such as an Illumina or Illumina X Ten, where it is sequenced using a technique called single-end or paired-end sequencing.\n4. Data analysis: The raw sequencing data is then analyzed using specialized software to identify and quantify the miRNAs present in the sample.\nMIRA-seq has several advantages over other methods for miRNA analysis, including its high sensitivity and specificity, as well as its ability to analyze thousands of miRNAs in a single run. It has been used to study a wide range of biological processes, including cancer, development, and immunology."
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "ARCALYST (rilonacept) is a prescription medication used to treat cryopyrin-associated periodic syndromes (CAPS), which are a group of rare genetic disorders that can cause recurring episodes of fever, pain, and swelling. Specifically, ARCALYST is approved for the treatment of cryopyrin-associated periodic syndrome (CAPS), including familial cold autoinflammatory syndrome (FCAS) and migraine-like headaches associated with CAPS."
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "Robertsonian translocations involve the exchange of genetic material between two acrocentric chromosomes, which are defined as chromosomes that have their centromere near their telomeres. Of the 23 human chromosomes, the following acrocentric chromosomes are involved in Robertsonian translocations:\n1. Chromosome 13\n2. Chromosome 14\n3. Chromosome 15\n4. Chromosome 16\nThese chromosomes are more prone to translocations due to their compact structure and proximity to the centromere, which makes it easier for genetic material to exchange between them."
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "There are several R packages that can be used for the identification of pediatric brain tumors, including:\n1. `pediatricbraintumor`: This package provides a comprehensive set of tools for the analysis of pediatric brain tumors, including gene expression analysis, survival analysis, and mutation analysis.\n2. `brainTumor`: This package provides a set of functions for the analysis of brain tumors, including gene expression analysis, survival analysis, and mutation analysis.\n3. `rptk`: This package provides a set of functions for the analysis of retinoblastoma gene mutations, which are commonly found in pediatric brain tumors.\n4. `pediatric`: This package provides a set of functions for the analysis of pediatric cancers, including brain tumors.\n5. `cancer`: This package provides a set of functions for the analysis of various types of cancer, including brain tumors.\n6. `genefunction`: This package provides a set of functions for the analysis of gene expression and mutation in various types of cancer, including brain tumors.\n7. `limma`: This package provides a set of functions for the analysis of gene expression data, which can be used to identify differentially expressed genes in pediatric brain tumors.\n8. `edgeR`: This package provides a set of functions for the analysis of RNA sequencing data, which can be used to identify differentially expressed genes in pediatric brain tumors.\n9. `ggplot2`: This package provides a set of functions for the visualization of gene expression data, which can be used to identify patterns of gene expression in pediatric brain tumors.\n10. `survival`: This package provides a set of functions for the analysis of survival data, which can be used to identify genes that are associated with poor prognosis in pediatric brain tumors.\nIt's worth noting that the specific R package you choose will depend on the type of analysis you want to perform and the data you have available."
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "No, NEMO (Nuclear Envelope-Associated Matrix-Organizing) is not a zinc finger protein. NEMO is a protein that plays a crucial role in the immune system, specifically in the activation of the NF-κB signaling pathway. It does not contain any zinc finger domains, which are a characteristic feature of zinc finger proteins."
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Yes, TFIIS (Transcription Factor IIS) plays a role in nucleosome positioning. TFIIS is a transcription factor that helps to regulate the initiation of transcription in eukaryotic cells, particularly during the process of transcription elongation. TFIIS has been shown to interact with nucleosomes and can affect their positioning on DNA, thereby influencing the accessibility of the transcriptional machinery to the DNA template. Specifically, TFIIS has been shown to displace nucleosomes from the promoter region of actively transcribed genes, allowing for the recruitment of RNA polymerase and other transcription factors. This process is important for the proper regulation of gene expression and ensures that RNA polymerase can access the DNA template to initiate transcription."
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "Based on the information provided, origins of replication near yeast centromeres fire early."
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences are characterized by the following properties:\n1. Long range orientation: Mammalian GA-sequences are typically long, with a range of 10-20 nucleotides, and are oriented in a head-to-head or head-to-tail manner.\n2. High GC content: Mammalian GA-sequences have a high GC content, typically ranging from 50-70%, which is higher than the GC content of non-GA sequences.\n3. Low complexity: Mammalian GA-sequences have low complexity, with a low number of nucleotides and a low frequency of palindromic or imperfect repeats.\n4. High stability: Mammalian GA-sequences are highly stable, with a high Tm value (melting temperature) and a low frequency of secondary structure formation.\n5. Evolutionary conservation: Mammalian GA-sequences are highly conserved across species, indicating their functional importance in mammalian cells.\n6. Regulation of transcriptional elongation: Mammalian GA-sequences are involved in the regulation of transcriptional elongation, with some GA-sequences acting as enhancers or silencers of gene expression.\n7. Chromatin remodeling: Mammalian GA-sequences can also be involved in chromatin remodeling, with some GA-sequences acting as recognition elements for chromatin-remodeling complexes.\n8. Non-coding RNA function: Some mammalian GA-sequences have been shown to function as non-coding RNAs, with roles in regulating gene expression, chromatin structure, and cellular processes.\n9. Genetic variation: Mammalian GA-sequences can be subject to genetic variation, with some studies suggesting that certain GA-sequences may be associated with disease susceptibility or resistance.\n10. Evolutionary origins: Mammalian GA-sequences have evolved from a common ancestor with other eukaryotic GA-sequences, and share many similarities with other GA-sequences found in organisms such as yeast and Drosophila."
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "There are 4 Groucho-related genes (GRG) contained in the mouse genome: Grm1, Grm2, Grm3, and Grm4."
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II (RNAPII) is a complex of several subunits, and only one of the subunits, RNAPII subunit B (RPB1), carries RNA cleavage activity. RPB1 is responsible for the cleavage of the RNA transcript during transcription elongation, which is necessary for the proper termination of transcription."
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is caused by mutations in the gene encoding the protein neuroserpin, which is involved in the regulation of blood coagulation and inflammation. Specifically, mutations in the SERPINI1 gene on chromosome 1q21 can lead to the development of Ohdo syndrome."
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package \"psychgene\" has been developed for the analysis of psychiatric disease genes. It provides a comprehensive set of tools for the analysis of genetic data in psychiatric disorders, including gene-level association analysis, pathway analysis, and gene-set enrichment analysis."
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "Swirl sign, also known as the \"whirlpool sign,\" is a radiological finding observed in some cases of intracerebral hemorrhage (ICH). It is characterized by a spiral or whirlpool-like configuration of the blood clot or hematoma in the affected brain area.\nThe swirl sign is thought to occur due to the rotation of the blood clot or hematoma around its center of gravity, which is often caused by the blood flow in the surrounding vasculature. This rotation can lead to the formation of a spiral or whirlpool-like pattern in the clot or hematoma, which can be visualized on CT or MRI scans.\nThe swirl sign can be observed in various locations in the brain, including the cerebral cortex, basal ganglia, thalamus, and cerebellum. It is more commonly seen in hemorrhages that occur in the deeper brain structures, such as those in the basal ganglia or thalamus.\nThe swirl sign is not specific to ICH and can also be seen in other conditions such as subarachnoid hemorrhage, cerebral vasculitis, and brain tumors. However, its presence is often associated with a poorer prognosis in ICH patients, as it may indicate a larger and more extensive hemorrhage.\nThe swirl sign can be detected on CT or MRI scans, typically within the first 24-48 hours after the onset of symptoms. The sign may be more visible on MRI than on CT, as it is more sensitive to the subtle changes in water content in the brain tissue.\nIn conclusion, the swirl sign is a radiological finding that can be observed in some cases of intracerebral hemorrhage. It is characterized by a spiral or whirlpool-like configuration of the blood clot or hematoma in the affected brain area, and is often associated with a poorer prognosis."
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Arabidopsis ROF1 (RNA polymerase II-associated factor 1) expression is induced by various environmental and developmental signals, including:\n1. Light: Light signals can induce ROF1 expression in Arabidopsis, leading to increased transcriptional activity and gene expression.\n2. Temperature: ROF1 expression is also temperature-sensitive, with higher expression at higher temperatures.\n3. Water availability: ROF1 expression can be induced in response to drought or other stress conditions, suggesting its role in regulating gene expression related to stress response.\n4. Hormones: ROF1 expression can be regulated by various hormones, including auxin, cytokinin, and ethylene, which can affect gene expression related to cell growth and differentiation.\n5. Developmental cues: ROF1 expression can also be regulated by developmental signals, such as those related to cell division and differentiation, leading to changes in gene expression during plant development."
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common cause of hereditary renal amyloidosis is the protein transthyretin (TTR). TTR amyloidosis, also known as familial amyloidotic polyneuropathy (FAP), is a group of inherited disorders that result from mutations in the TTR gene, leading to the accumulation of abnormal TTR proteins in various tissues, including the kidneys, and causing progressive damage and loss of function."
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been extensively analyzed. The hippocampus is a complex brain region involved in various cognitive and emotional processes, and its proteome has been studied in detail to gain insights into its function and dysfunction in various diseases.\nSome of the key studies on the proteome of the mouse hippocampus include:\n1. The first comprehensive analysis of the mouse hippocampal proteome was published in 2003 by a group led by Dr. Eric Johnson at the University of California, Los Angeles (UCLA). This study identified over 2,000 proteins in the hippocampus and provided a framework for understanding the regional distribution of proteins in the brain.\n2. In 2006, a study by Dr. David W. Andrews at the University of California, San Diego, used a proteomics approach to investigate changes in the hippocampal proteome following seizures in mice. The study identified several proteins that were differentially expressed in the hippocampus after seizures, including proteins involved in excitotoxicity and inflammation.\n3. A 2011 study by Dr. Mark S. Sonders and colleagues at the University of Pennsylvania used a combination of mass spectrometry and antibody-based methods to identify and quantify proteins in the mouse hippocampus. The study identified over 1,000 proteins in the hippocampus and provided insights into the regional distribution of proteins in the brain.\n4. In 2013, a study by Dr. Michael E. Greenberg at Harvard Medical School used a proteomics approach to investigate changes in the hippocampal proteome following exposure to the psychostimulant drug cocaine. The study identified several proteins that were differentially expressed in the hippocampus after cocaine exposure, including proteins involved in synaptic plasticity and neurotransmission.\n5. A 2016 study by Dr. Renee M. Ryan and colleagues at the University of California, San Francisco, used a combination of mass spectrometry and bioinformatics tools to identify and characterize the proteins in the mouse hippocamp"
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are characterized by a large centromere and a short arm (p arm), and are typically found in mammalian species such as humans and primates. Mouse chromosomes, on the other hand, are metacentric, meaning that the centromere is located near the middle of the chromosome."
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "There are several siRNA-based drugs in clinical trials for the treatment of pancreatic cancer, including:\n1. ONC205: ONC205 is an siRNA-based drug that targets the gene encoding the protein PD-L1 (programmed death-ligand 1). It is being developed by OncoGenex Pharmaceuticals and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\n2. RX-0201: RX-0201 is an siRNA-based drug that targets the gene encoding the protein KRAS (Kirsten rat sarcoma viral oncogene homolog). It is being developed by Rexahn Pharmaceuticals and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\n3. BSI-201: BSI-201 is an siRNA-based drug that targets the gene encoding the protein Bcl-2 (B-cell lymphoma 2). It is being developed by BioSight Pharmaceuticals and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\nIt is important to note that these drugs are still in the experimental stage and have not yet been approved by regulatory authorities for use in humans."
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG (Hexamethylene Glycol) pore is a type of ion channel that is found in the inner mitochondrial membrane. It is a small, non-selective pore that allows the passage of small molecules, such as ions and small metabolites, between the cytosol and the mitochondrial matrix. The HPG pore plays a critical role in regulating the metabolism of the mitochondria, particularly in the context of cellular stress and energy metabolism."
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematodes, which are a group of microscopic worms that include parasitic and free-living species. The initiative was launched in 2017 and is led by the University of California, Riverside (UCR) in collaboration with several other institutions.\nNematodes are a diverse group of organisms that play important roles in ecosystems, including as plant parasites, decomposers, and symbionts. However, their genomes have been relatively understudied compared to those of other organisms, such as animals and plants. The 959 Nematode Genomes initiative aims to change this by generating high-quality genome sequences for a large number of nematode species, which will provide new insights into their evolution, biology, and interactions with their environments.\nThe initiative is using a combination of next-generation sequencing technologies and bioinformatic tools to generate genome assemblies for the 959 nematode species. The project also includes a comprehensive analysis of the genomes, including the identification of genes, regulatory elements, and other features. The data generated by the initiative will be made publicly available through a database, which will provide a valuable resource for researchers studying nematodes and their roles in ecosystems.\nOverall, the 959 Nematode Genomes initiative is an ambitious and exciting project that will help to advance our understanding of these fascinating organisms and their importance in the natural world."
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the popular ones include:\n1. NIPT: This package provides a set of functions for analyzing NIPT data, including data cleaning, filtering, and statistical analysis.\n2. Prenat: This package provides a comprehensive set of functions for the analysis of NIPT data, including data cleaning, filtering, and statistical analysis.\n3. PrenatalTesting: This package provides a set of functions for analyzing NIPT data, including data cleaning, filtering, and statistical analysis.\n4. NIPTAnalysis: This package provides a set of functions for analyzing NIPT data, including data cleaning, filtering, and statistical analysis.\n5. PrenatalGenetics: This package provides a set of functions for analyzing NIPT data, including data cleaning, filtering, and statistical analysis.\nIt is important to note that these packages may have different functionalities and user interfaces, and the choice of package may depend on the specific requirements of the analysis."
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare genetic disorder that affects the development of the brain and nervous system. It is characterized by a combination of intellectual disability, seizures, and distinctive facial features, including a flat nasal bridge, widely spaced eyes, and a small jaw. Other symptoms can include delayed speech and language development, motor delays, and behavioral problems. The exact cause of Achenbach's syndrome is not known, but it is thought to be due to a mutation in a gene that is important for brain development. The disorder is usually diagnosed in early childhood and can be identified through a combination of clinical evaluation, imaging studies, and genetic testing. Treatment for Achenbach's syndrome typically involves a multidisciplinary approach, including medication for seizures and behavioral problems, as well as therapies to help improve cognitive and motor function."
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "Long repeat expansions are typically detected using algorithms that are designed to identify repetitive sequences in DNA. Some common algorithms used for this purpose include:\n1. RepeatMasker: This is a widely used algorithm that can identify repetitive sequences in DNA, including long repeat expansions. It works by comparing the query sequence to a database of known repeat sequences and identifying any matches.\n2. RepeatFinder: This algorithm is similar to RepeatMasker, but it is more sensitive and can identify smaller repeat elements. It uses a probabilistic approach to identify repeat sequences and can be used to detect both short and long repeat expansions.\n3. Gapped Repeat Finder: This algorithm uses a combination of computational and statistical methods to identify repeat sequences in DNA. It can be used to detect both short and long repeat expansions and is particularly useful for identifying repeat sequences that are interrupted by gaps in the DNA sequence.\n4. Long Repeat Finder: This algorithm is specifically designed to identify long repeat expansions in DNA. It uses a combination of computational and statistical methods to identify repeat sequences and can be used to detect both repetitive and non-repetitive sequences.\n5. HMMER: This algorithm uses a hidden Markov model to identify repeat sequences in DNA. It can be used to detect both short and long repeat expansions and is particularly useful for identifying repeat sequences that are highly conserved across different species.\nThese algorithms are widely used in bioinformatics and genomics to identify long repeat expansions in DNA sequences. The choice of algorithm will depend on the specific research question and the characteristics of the DNA sequence being analyzed."
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 has been implicated in the development and progression of certain types of brain tumors, including:\n* Glioblastoma (GBM): Neuroligin-3 is overexpressed in a majority of GBM cases and has been linked to tumor progression and poor prognosis.\n* Medulloblastoma: Neuroligin-3 is also overexpressed in medulloblastoma, a type of pediatric brain cancer that originates in the cerebellum.\n* Other brain tumors: Neuroligin-3 has also been found to be overexpressed in other types of brain tumors, including pineal parenchymal tumors, meningioma, and acoustic neuroma.\nIt's worth noting that the exact role of neuroligin-3 in the development and progression of these tumors is still being studied and debated, and more research is needed to fully understand its involvement."
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles in bacteria are typically around 10-50 nanometers (nm) in diameter, although they can range in size from a few nm to several hundred nm."
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that play a crucial role in regulating gene expression by modifying chromatin structure. Here are some of the BET proteins that have been identified:\n1. BRD2 (Bromodomain-Containing Protein 2): This protein is the most well-studied member of the BET family and has been implicated in a variety of cellular processes, including transcriptional activation, DNA damage response, and cancer.\n2. BRD3 (Bromodomain-Containing Protein 3): Similar to BRD2, BRD3 has been linked to a range of cellular processes, including transcriptional regulation, cell proliferation, and cancer.\n3. BRDT (Bromodomain-Containing Protein T): This protein is a member of the BET family that is primarily expressed in the testis and has been implicated in the regulation of gene expression during spermatogenesis.\n4. BRDM2 (Bromodomain-Containing Protein 2-Like 2): This protein is a paralog of BRD2 and shares similar functions and properties.\n5. BRD4 (Bromodomain-Containing Protein 4): This protein is a member of the BET family that has been implicated in a variety of cellular processes, including transcriptional regulation, cell proliferation, and cancer.\n6. BRD3L1 (Bromodomain-Containing Protein 3-Like 1): This protein is a paralog of BRD3 and shares similar functions and properties.\n7. BRD3L2 (Bromodomain-Containing Protein 3-Like 2): This protein is another paralog of BRD3 that has been implicated in similar cellular processes.\n8. BRD4L (Bromodomain-Containing Protein 4-Like): This protein is a paralog of BRD4 that has been linked to a range of cellular processes, including transcriptional regulation and cancer.\n9. BET1 (Bromodomain-Containing Protein 1): This protein is a member of the BET family that is primarily expressed in the brain and has been imp"
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "One algorithm that has been developed for predicting protein subcellular localization using deep learning is the \"DeepLoc\" algorithm. It was proposed by the group of Zhang et al. in 2015 and has been shown to achieve state-of-the-art performance on several protein subcellular localization benchmarks.\nDeepLoc is a deep learning-based method that uses a convolutional neural network (CNN) to predict protein subcellular localization. The algorithm takes as input a protein sequence and outputs a probability distribution over the possible subcellular localizations (such as cytoplasm, nucleus, membrane, etc.). The CNN is trained on a large dataset of protein sequences and their corresponding subcellular localizations, and the learning process is optimized using a combination of cross-entropy loss and transfer learning.\nDeepLoc has been shown to outperform other machine learning-based localization methods, including support vector machines (SVMs) and random forests, on several benchmark datasets. It has also been used to predict the localization of proteins in a variety of organisms, including bacteria, yeast, and humans.\nOverall, DeepLoc is a powerful tool for predicting protein subcellular localization using deep learning, and it has the potential to be used for a wide range of applications in bioinformatics and functional genomics."
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "MULTOVL is not a term or a protein that I am familiar with in the context of molecular biology. It is possible that it is a misspelling or a term used in a specific context or field that I am not aware of. Can you please provide more information or context about where you encountered this term?"
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "Yes, GDF15 has been identified as a potential biomarker for metformin treatment. Studies have shown that GDF15 levels are increased in response to metformin treatment in patients with type 2 diabetes, and that this increase is associated with improved insulin sensitivity and glucose metabolism. Therefore, GDF15 could potentially be used as a biomarker to monitor the effectiveness of metformin treatment and to identify patients who are likely to respond to this medication."
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Yes, recursive splicing is more common in short introns. Recursive splicing, also known as intron circularization, occurs when the splicing machinery recognizes and splices the same intron multiple times, resulting in the formation of a circular splicing pattern. This type of splicing is more likely to occur in short introns, which have a shorter length and may have a higher concentration of splicing sites, making it more likely for the splicing machinery to encounter the same intron multiple times."
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "TALE-iD is a method used for identifying the functional elements in a genome, such as enhancers, silencers, and promoters, by using a technique called CRISPR-Cas9-based genome editing. TALE-iD stands for TALE-based Identification of Regulatory Elements, and it is used to identify the specific locations in the genome where these functional elements are located."
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. CL-Image: A Lisp library for image processing, featuring functions for image manipulation, filtering, and analysis.\n2. Lisp-Image: A Lisp image processing framework with support for image manipulation, analysis, and visualization.\n3. ImageTk: A Lisp interface to the Tk image processing toolkit, providing a simple and easy-to-use image processing environment.\n4. Drew: A Lisp image processing system that provides a high-level interface for image manipulation and analysis, with support for a wide range of image formats.\n5. Image-Lisp: A Lisp image processing library that provides a wide range of image processing functions, including filtering, resizing, and color manipulation.\nThese are just a few examples of the many Lisp frameworks available for image processing. Each one has its own unique features and capabilities, so it's worth exploring each one to determine which one is the best fit for your needs."
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "In Saccharomyces cerevisiae (baker's yeast), approximately 800-900 genes are the result of an ancient whole genome duplication. This duplication event occurred around 1000-2000 million years ago and is thought to have played a key role in the evolution of eukaryotic cells."
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "llama-2-7b-chat-hf_response": "Estrogen-related receptor β (Esrrb) binds to the complex of estrogen and estrogen-binding proteins, such as sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG)."
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17 is a zinc finger CCHC-type histone triad-containing protein that plays a crucial role in regulating gene expression by modulating the structure of chromatin. It is involved in the epigenetic modification of histone proteins, particularly histone H3, and helps to maintain the proper organization of chromatin structures during cell division. Additionally, ZCCHC17 has been implicated in the regulation of stem cell self-renewal and differentiation, as well as in the development and progression of certain cancers."
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The nuclear pore basket, also known as the nuclear pore complex (NPC), is composed of several proteins in human cells. The main proteins that make up the NPC are:\n1. Nucleoporin 1 (Nup1): This protein forms the central channel of the NPC and is responsible for nucleocytoplasmic transport.\n2. Nucleoporin 2 (Nup2): This protein forms the outer layer of the NPC and helps to regulate the transport of molecules between the nucleus and cytoplasm.\n3. Nucleoporin 3 (Nup3): This protein is involved in the assembly and maintenance of the NPC.\n4. Nucleoporin 4 (Nup4): This protein is a component of the NPC and helps to regulate the transport of molecules between the nucleus and cytoplasm.\n5. Nucleoporin 5 (Nup5): This protein is involved in the assembly and maintenance of the NPC.\n6. Nucleoporin 6 (Nup6): This protein is a component of the NPC and helps to regulate the transport of molecules between the nucleus and cytoplasm.\n7. Nucleoporin 7 (Nup7): This protein is involved in the assembly and maintenance of the NPC.\n8. Nucleoporin 8 (Nup8): This protein is a component of the NPC and helps to regulate the transport of molecules between the nucleus and cytoplasm.\n9. Nucleoporin 9 (Nup9): This protein is involved in the assembly and maintenance of the NPC.\n10. Nucleoporin 10 (Nup10): This protein is a component of the NPC and helps to regulate the transport of molecules between the nucleus and cytoplasm.\nThese proteins work together to form a complex that spans the nuclear envelope and regulates the transport of molecules between the nucleus and cytoplasm."
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a topoisomerase II inhibitor. Specifically, it is a type II topoisomerase inhibitor that selectively binds to and inhibits the activity of topoisomerase IIα (TopoIIα) in cancer cells, leading to the accumulation of topoisomerase II-mediated DNA damage and ultimately causing cell death."
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW (Small Molecule Wide-range) is a type of protein-protein interaction (PPI) assay that uses a small molecule ligand to capture and immobilize protein-protein interactions in a high-throughput manner. The assay is based on the concept of a \"canvas\" of small molecules that bind to specific protein-protein interactions, allowing for the detection and quantification of multiple interactions in a single assay.\nIn the Canvas SPW assay, a library of small molecules is used to capture and immobilize protein-protein interactions. The small molecules are designed to bind specifically to the interface between two proteins, creating a \"canvas\" of molecules that capture the interactions between the proteins. The captured interactions are then detected using a variety of methods, such as mass spectrometry or fluorescence microscopy.\nThe advantages of the Canvas SPW assay include:\n1. High-throughput: The assay can be performed in a high-throughput manner, allowing for the simultaneous detection and quantification of multiple protein-protein interactions.\n2. Sensitivity: The small molecule ligands used in the assay are highly specific and sensitive, allowing for the detection of weak protein-protein interactions.\n3. Multiplexing: The Canvas SPW assay can be multiplexed, allowing for the detection of multiple protein-protein interactions in a single assay.\n4. Low sample consumption: The assay requires only small amounts of sample material, making it ideal for studying rare or precious samples.\n5. Versatility: The Canvas SPW assay can be used to study protein-protein interactions in a variety of systems, including cellular, tissue, and biochemical assays.\n6. Cost-effective: The assay is relatively low-cost compared to other PPI assays, making it a cost-effective tool for protein-protein interaction research.\n7. Easy to use: The assay is relatively simple to perform and does not require extensive training or expertise.\n8. High accuracy: The assay provides highly accurate results, with low background and high specificity.\nIn summary, Canvas SPW is a powerful tool for studying protein-protein interactions in a high-throughput and cost-effective"
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "STING (Stimulator of Interferon Genes) is a protein that plays a crucial role in the innate immune response. STING agonists are compounds that activate STING and trigger an immune response. Here are some examples of STING agonists:\n1. PolyICLC: PolyICLC is a synthetic analog of the immunostimulatory CpG DNA, which is a common STING agonist.\n2. CpG ODN: CpG ODNs (CpG oligodeoxynucleotides) are synthetic CpG-containing DNA molecules that activate STING and stimulate an immune response.\n3. DNA-based vaccines: Some DNA-based vaccines, such as the HPV vaccine, contain STING agonists that can stimulate an immune response.\n4. Small molecule agonists: Some small molecules, such as cyclic dinucleotides (CDNs), have been identified as STING agonists and can stimulate an immune response.\n5. Peptide agonists: Some peptides, such as the peptide STING agonist, have been identified as STING agonists and can stimulate an immune response.\n6. Viral mimics: Some viral mimics, such as polyI:C, can activate STING and stimulate an immune response.\n7. Lipid agonists: Some lipid molecules, such as 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), have been identified as STING agonists and can stimulate an immune response.\n8. Glycosaminoglycan: Some glycosaminoglycans, such as heparan sulfate, have been identified as STING agonists and can stimulate an immune response.\n9. Protein agonists: Some proteins, such as the protein STING agonist, have been identified as STING agonists and can stimulate an immune response.\n10. Plant-derived compounds: Some plant-derived compounds, such as the flavonoid quercetin, have been identified as ST"
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": "SLIC-CAGE (Slicing-based Chromatin Accessibility Genome Engineering) is a genome engineering technology that allows for the precise modification of chromatin structure and accessibility. It is a powerful tool for studying the interplay between chromatin structure and gene expression, and for manipulating gene expression in a precise and targeted manner.\nIn SLIC-CAGE, a specific DNA sequence is identified and targeted using a CRISPR-Cas13 system. The CRISPR-Cas13 system is programmed to recognize a specific protospacer adjacent motif (PAM) sequence in the target DNA, and when the CRISPR-Cas13 complex binds to the target site, it cleaves the DNA. The cleavage event is then used as a signal to introduce a specific DNA modification, such as a base modification or a DNA insertion, at the target site.\nThe SLIC-CAGE technology takes advantage of the fact that the CRISPR-Cas13 system can also be used as a \"slicing\" tool, cutting the DNA at specific locations and creating a double-stranded break. This break can then be repaired by the cell's own repair machinery, leading to the introduction of specific DNA modifications.\nSLIC-CAGE has a number of advantages over other genome engineering technologies. It is highly precise and efficient, with a high on-target rate and low off-target rate. It also allows for the simultaneous modification of multiple sites in the genome, making it a powerful tool for studying the interplay between multiple genetic elements. Additionally, the SLIC-CAGE technology can be used to modify the genome of a wide range of organisms, including bacteria, yeast, and mammalian cells.\nOverall, SLIC-CAGE is a powerful tool for manipulating the genome and studying the interplay between chromatin structure and gene expression. Its high precision and efficiency make it a valuable tool for a wide range of applications, including basic research, biotechnology, and medicine."
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 (LEM domain-containing protein 3) is a protein that plays several important roles in the cell, including:\n1. Chromatin remodeling: LEM-3 is involved in the remodeling of chromatin structure, particularly during transcriptional elongation. It helps to displace nucleosomes and facilitate the binding of RNA polymerase to the DNA template.\n2. Transcriptional regulation: LEM-3 can bind to specific DNA sequences and modulate the recruitment of transcription factors, thereby regulating gene expression.\n3. Cell cycle progression: LEM-3 has been implicated in the regulation of the G1/S checkpoint and the progression of cells through the cell cycle. It may play a role in the regulation of cyclin-dependent kinase activity and the stability of cyclins.\n4. Apoptosis: LEM-3 has been shown to promote apoptosis (programmed cell death) in certain contexts, such as during cancer development or in response to DNA damage.\n5. Nuclear organization: LEM-3 is involved in the organization of nuclear structures, such as the nuclear lamina and the nuclear pore complex. It may play a role in maintaining the integrity of these structures and in regulating nuclear transport."
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "As a helpful assistant, I apologize, but I'm a large language model, I cannot provide you with the releases of tmVar as it is a fictional software. Therefore, I cannot provide you with any information about its releases. However, I can assist you with any other questions or tasks you may have. Please feel free to ask me anything!"
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "There is no comprehensive database of somatic mutations in normal cells. The majority of genetic mutation databases, such as COSMIC, Cancer Genome Atlas (TCGA), and ExAC, focus on identifying somatic mutations in cancer cells. These databases contain information on mutations found in cancer tissues, but do not include data on mutations present in normal tissues.\nHowever, there are some recent studies that have begun to investigate the genetic landscape of normal tissues, including the identification of somatic mutations in non-cancerous cells. For example, the \"Mutational Signature of Somatic Mutations in Normal Tissues\" study published in the journal Nature in 2019 found that normal tissues, such as liver, lung, and blood, have a low rate of somatic mutations, and that these mutations tend to be concentrated in specific genes and genomic regions.\nIt's worth noting that while there are no comprehensive databases of somatic mutations in normal cells, there are several resources that provide information on the frequency and distribution of genetic mutations in different tissues and populations, such as the 1000 Genomes Project and the Exome Aggregation Consortium (ExAC). These resources can be useful for understanding the genetic variation in different populations and tissues, but they do not provide direct information on somatic mutations in normal cells."
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "Yes, there are several graph kernel libraries available that are implemented in Java. Here are some popular ones:\n1. JGraphT: JGraphT is a Java library for graph theory that provides a simple and efficient way to create, manipulate, and analyze graphs. It supports a wide range of graph algorithms and can be used for both directed and undirected graphs.\n2. Weka: Weka is a Java library for data mining and machine learning that includes a graph kernel module. The graph kernel module provides a set of classes and interfaces for implementing graph-based algorithms, including graph kernel methods.\n3. GraphCrunch: GraphCrunch is a Java library for graph processing that provides a simple and efficient way to perform graph computations. It supports a wide range of graph algorithms and can be used for both directed and undirected graphs.\n4. GraphXR: GraphXR is a Java library for graph processing that provides a set of classes and interfaces for implementing graph-based algorithms. It supports a wide range of graph algorithms and can be used for both directed and undirected graphs.\n5. GraphMol: GraphMol is a Java library for molecular graph processing that provides a simple and efficient way to perform graph computations on molecular graphs. It supports a wide range of graph algorithms and can be used for both directed and undirected graphs.\nThese libraries can be used for various applications such as social network analysis, recommendation systems, fraud detection, and more. However, it is important to note that the availability and quality of these libraries may vary, and you should carefully evaluate them based on your specific requirements before selecting one for your project."
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "The SHERLOCKv2 platform has integrated four advances in molecular diagnostics:\n1. CRISPR-Cas13: SHERLOCKv2 uses the CRISPR-Cas13 system to detect target RNA molecules by degrading them, allowing for highly sensitive and specific detection.\n2. RNA-targeted probes: The platform utilizes RNA-targeted probes that are complementary to the target RNA sequence, allowing for efficient and specific binding to the target.\n3. Enzymatic amplification: SHERLOCKv2 employs enzymatic amplification of the target RNA using a thermostable DNA polymerase, which allows for efficient amplification of the target sequence.\n4. Digital PCR: The platform uses digital PCR to quantify the amount of the target RNA in the sample, providing a highly accurate and sensitive measure of the target."
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a machine learning algorithm used for feature selection and dimensionality reduction in high-dimensional datasets. It was introduced by A. Smola and B. Schölkopf in 2004.\nThe algorithm works by iteratively selecting the most relevant features and projecting the data onto a lower-dimensional space. The selection of features is based on the idea of \"drinking\" from a set of candidate features, where the algorithm selects the feature that is most likely to be relevant to the underlying pattern in the data.\nThe algorithm can be summarized in the following steps:\n1. Initialize the set of selected features: The algorithm starts with an empty set of selected features.\n2. Drink from the candidate set: The algorithm selects a candidate feature from the set of all possible features and computes the projection of the data onto the subspace defined by that feature.\n3. Evaluate the relevance of the selected feature: The algorithm evaluates the relevance of the selected feature to the underlying pattern in the data using a relevance measure, such as mutual information.\n4. Select the most relevant feature: The algorithm selects the feature that has the highest relevance measure and adds it to the set of selected features.\n5. Project the data onto the selected subspace: The algorithm projects the data onto the subspace defined by the selected features using a linear projection.\n6. Repeat steps 2-5: The algorithm repeats steps 2-5 until a stopping criterion is reached, such as a maximum number of iterations or a minimum level of relevance.\n7. Output the selected features: The algorithm outputs the set of selected features that have been identified as most relevant to the underlying pattern in the data.\nThe Bartender algorithm has several advantages over other feature selection algorithms, including:\n* It can handle high-dimensional datasets: The algorithm can handle datasets with a large number of features, making it particularly useful for applications where the number of features is much larger than the number of samples.\n* It is robust to noise: The algorithm is robust to noise in the data, as it uses a relevance measure to evaluate the relevance of each feature rather than simply selecting the most highly correlated features.\n* It can handle non-linear relationships: The algorithm can handle non-linear relationships between the features and the underlying pattern in the data, as it projects the data onto a lower-dimensional space using a linear projection."
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "There are several web-based pedigree editors available, including:\n1. Pedigree.io: A free, web-based tool that allows users to create and edit family trees. It offers features such as drag-and-drop functionality, automatic merging of duplicate profiles, and the ability to add sources and citations.\n2. FamilySearch: A free, web-based platform that allows users to create and edit family trees. It offers features such as a large database of historical records, collaboration tools, and the ability to add sources and citations.\n3. MyHeritage: A web-based platform that allows users to create and edit family trees. It offers features such as a large database of historical records, collaboration tools, and the ability to add sources and citations.\n4. GenoPro: A commercial web-based tool that allows users to create and edit family trees. It offers features such as customizable templates, collaboration tools, and the ability to add sources and citations.\n5. FamilyTreeMaker: A commercial web-based tool that allows users to create and edit family trees. It offers features such as a large database of historical records, collaboration tools, and the ability to add sources and citations.\n6. Legacy Family Tree: A commercial web-based tool that allows users to create and edit family trees. It offers features such as a large database of historical records, collaboration tools, and the ability to add sources and citations.\n7. Ancestry.com: A commercial web-based platform that allows users to create and edit family trees. It offers features such as a large database of historical records, collaboration tools, and the ability to add sources and citations.\n8. WeRelate: A free, web-based platform that allows users to create and edit family trees. It offers features such as collaboration tools, and the ability to add sources and citations.\n9. WikiTree: A free, web-based platform that allows users to create and edit family trees. It offers features such as collaboration tools, and the ability to add sources and citations.\n10. Gramps: A free, open-source, web-based platform that allows users to create and edit family trees. It offers features such as collaboration tools, and the ability to add sources and citations.\nPlease note that this is not an exhaustive list and there may be other web-based pedigree editors"
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "There are several curated databases available for spider-venom toxins, including:\n1. ToxinDB: A comprehensive database of toxins from various sources, including spiders, snakes, and scorpions.\n2. Spider Toxin Database (STD): A database of spider venom toxins, including their structures, functions, and pharmacological activities.\n3. Venom-DB: A database of venom peptides and proteins from various organisms, including spiders, snakes, and scorpions.\n4. Natural Products Alert (NPA): A database of natural products, including spider venom toxins, with information on their chemical structures, biological activities, and potential applications.\n5. ToxinTracer: A database of toxins from various sources, including spiders, snakes, and scorpions, with information on their structures, functions, and pharmacological activities.\n6. Spider Venom Toxin Database (SVTD): A database of spider venom toxins, including their structures, functions, and pharmacological activities.\n7. Venom-Tox: A database of venom peptides and proteins from various organisms, including spiders, snakes, and scorpions, with information on their structures, functions, and pharmacological activities.\n8. Toxinology: A database of toxins from various sources, including spiders, snakes, and scorpions, with information on their structures, functions, and pharmacological activities.\n9. Venomics: A database of venom peptides and proteins from various organisms, including spiders, snakes, and scorpions, with information on their structures, functions, and pharmacological activities.\n10. ToxinTech: A database of toxins from various sources, including spiders, snakes, and scorpions, with information on their structures, functions, and pharmacological activities.\nThese databases provide valuable information on the various spider-venom toxins and their potential applications in medicine, agriculture, and other fields."
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "Based on the information provided, it seems that Axitinib does not prolong survival of pancreatic cancer patients. The text states that \"Axitinib, a tyrosine kinase inhibitor, has shown promise in the treatment of pancreatic cancer, but its effect on overall survival has been limited.\" This suggests that while Axitinib may have some benefits in treating pancreatic cancer, it has not been shown to significantly improve overall survival in these patients."
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP (Microtubule-associated protein) regulates F-actin dynamics through its interaction with the F-actin protein, actin-binding protein 1 (ABP-1). MLP interacts with ABP-1 and promotes the assembly and stability of F-actin structures."
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "According to current estimates, there are approximately 100-150 pseudokinases in the human kinome. These pseudokinases are proteins that have some characteristics of kinases, such as the ability to bind ATP and interact with other proteins, but they do not have the catalytic activity of a true kinase."
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are compounds that mimic the structure and function of apolipoprotein E (apoE), a protein involved in lipid metabolism and cholesterol transport. Here are three examples of apoE mimetics:\n1. ApoE mimetic peptides: These are small peptides that mimic the structure of apoE and have been shown to have anti-inflammatory and anti-atherogenic effects in various studies.\n2. ApoE-mimetic liposomes: These are liposomes that are engineered to mimic the structure of apoE and have been shown to be effective in reducing cholesterol accumulation in liver and improving insulin sensitivity in animal models of metabolic disorders.\n3. ApoE-mimetic small molecules: These are small molecules that mimic the structure of apoE and have been shown to have anti-inflammatory and anti-atherogenic effects in various studies. They have the potential to be used as therapeutic agents for the treatment of metabolic disorders such as atherosclerosis and Alzheimer's disease."
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "SAMHD1 (SAM and HD-like protein 1) is an enzyme that plays a crucial role in regulating the innate immune response to viral infections. There are sex differences in SAMHD1 activity, with studies suggesting that females have higher levels of SAMHD1 activity compared to males.\nOne study published in the journal Nature Communications found that female mice have higher levels of SAMHD1 activity in their brains compared to males, which may contribute to the higher susceptibility of females to certain neurodegenerative diseases, such as Alzheimer's disease.\nAnother study published in the journal Cell Reports found that female human cells have higher levels of SAMHD1 activity than male cells, which may make females more resistant to certain viral infections.\nThese findings suggest that sex differences in SAMHD1 activity may play a role in the different susceptibility of males and females to certain diseases, and may have important implications for the development of new treatments for these diseases."
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "No, RUNX2 (RUNX2, also known as AML1 or CBFA2) has been shown to promote astrocyte differentiation."
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "The Cobb-Stansby excision arthroplasty is a surgical procedure that is performed to treat a condition called avascular necrosis of the femoral head, which is a condition where the blood supply to the femoral head (the ball of the hip joint) is disrupted, leading to the death of the bone tissue. This procedure is typically performed by an orthopedic surgeon in an operating room setting, and the location of the procedure will depend on the severity of the condition and the individual patient's needs.\nIn general, the Cobb-Stansby excision arthroplasty is performed through a surgical incision on the side of the hip, usually over the gluteus maximus muscle. The surgeon will then expose the femoral head and remove the dead bone tissue using a specialized instrument called a curette. The surgeon may also remove any bone spurs or other bone fragments that may be present.\nAfter the dead bone tissue has been removed, the surgeon will fill the resulting cavity with a special bone graft material or with a synthetic bone substitute. This helps to maintain the shape of the femoral head and promote healing. The incision is then closed, usually with sutures or staples, and the patient is taken to the recovery room for post-operative care."
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "GRHL2 over-expression has been shown to promote epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells. EMT is a process by which epithelial cells lose their cell-cell adhesion and gain mesenchymal characteristics, such as increased motility and invasiveness. GRHL2 has been shown to play a key role in this process by regulating the expression of genes involved in EMT, such as E-cadherin and vimentin."
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "T-bet (T-box transcription factor Eomesodermin) and UCHL1 (ubiquitin C-terminal hydrolase 1) have been implicated in lung cancer."
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151 (G protein-coupled receptor 151) is an orphan receptor, meaning that it does not have a well-defined endogenous ligand or a clear physiological function. However, GPR151 has been found to be involved in a variety of cellular processes, including:\n1. Glucose metabolism: GPR151 has been shown to be involved in the regulation of glucose-stimulated insulin secretion and glucose uptake in insulin-sensitive cells.\n2. Lipid metabolism: GPR151 has been implicated in the regulation of lipid metabolism, including the expression of genes involved in lipid uptake and storage.\n3. Inflammation: GPR151 has been shown to play a role in the regulation of inflammatory responses, including the expression of genes involved in the production of pro-inflammatory cytokines.\n4. Cell proliferation and differentiation: GPR151 has been implicated in the regulation of cell proliferation and differentiation, including the expression of genes involved in cell cycle progression and differentiation.\n5. Neuroprotection: GPR151 has been shown to have neuroprotective effects, including the protection of neurons against oxidative stress and excitotoxicity.\nOverall, GPR151 is a multifunctional receptor that is involved in a variety of cellular processes, and its dysregulation has been implicated in a number of diseases, including metabolic disorders, inflammatory disorders, and neurodegenerative diseases."
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "The Fluzone Intradermal Quadrivalent vaccine contains the following attenuated live viruses:\n1. H1N1\n2. H3N2\n3. B/Victoria\n4. B/Yamagata"
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE) in the 3' untranslated region (3' UTR). Specifically, mutations in the TNFR2 3' UTR have been identified as a risk factor for SLE."
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "Currently, there is no licensed vaccine available for the prevention of peanut allergy. Researchers are actively working on developing a peanut allergy vaccine, but it is still in the experimental stage and has not yet been approved for use in humans.\nSeveral approaches are being explored to develop a peanut allergy vaccine, including:\n1. Oral immunotherapy: This involves gradually exposing individuals to small amounts of peanut protein in a controlled manner to build up tolerance.\n2. Epicutaneous immunotherapy: This involves delivering small amounts of peanut protein directly to the skin, where it is absorbed and can help build up tolerance.\n3. mRNA-based vaccines: This involves using messenger RNA (mRNA) to encode for peanut proteins, which are then expressed in the body and can help build up tolerance.\n4. Adjuvated vaccines: This involves using adjuvants, such as aluminum salts, to enhance the immune response to the peanut protein.\nWhile these approaches show promise, it may take several years before a peanut allergy vaccine becomes available for widespread use. It is important to note that a peanut allergy vaccine may not be effective for everyone and may not completely eliminate the risk of an allergic reaction. Therefore, it is crucial to continue to avoid peanuts and peanut products in the diet to prevent an allergic reaction."
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The mouse Fxy gene is located on the X chromosome."
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "MPE-seq is a method for sequencing RNA that is based on the chemistry of methidiumpropyl-EDTA (MPE), a reagent that selectively binds to RNA molecules and labels them for sequencing. The method involves treating the RNA sample with MPE, which selectively binds to the RNA molecules of interest, and then using a sequencing reaction to detect the MPE-labeled RNA fragments. The resulting sequencing data can be used to identify and quantify specific RNA molecules in the sample."
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "GWAR (Genome-Wide Association Study) is typically implemented using a programming language that is well-suited for handling large datasets and performing statistical analysis. Some common programming languages used for GWAR include:\n1. R: R is a popular programming language for statistical computing and graphics, and is widely used in the field of genetics and genomics. It has a large number of packages and functions available for performing GWAS, including the \"gwas\" package.\n2. Python: Python is a versatile programming language that is widely used in bioinformatics and genomics. It has a number of libraries and tools available for performing GWAS, including the \"pygsa\" library.\n3. MATLAB: MATLAB is a programming language that is commonly used in bioinformatics and genomics for performing statistical analysis and data visualization. It has a number of toolboxes available for performing GWAS, including the \"genomics toolbox\".\n4. SAS: SAS is a software suite that is widely used in the field of statistics and data analysis. It has a number of procedures available for performing GWAS, including the \"genetics procedure\".\n5. Julia: Julia is a new programming language that is gaining popularity in the field of bioinformatics and genomics. It has a number of packages and libraries available for performing GWAS, including the \"GWAS\" package.\nIt's worth noting that the choice of programming language will depend on the specific requirements of the analysis and the preferences of the researcher."
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Xaliproden (also known as deforolimus) is an investigational drug that has been shown to have potential in improving the prognosis of amyotrophic lateral sclerosis (ALS).\nStudies have suggested that xaliproden may slow down the progression of ALS by reducing the levels of a protein called SOD1, which is involved in the death of motor neurons in ALS patients. Additionally, xaliproden has been shown to increase the levels of a protein called neurotrophic factor, which can help to protect motor neurons from degeneration.\nWhile the results of these studies are promising, it's important to note that xaliproden is still an experimental drug and has not yet been approved by regulatory authorities for the treatment of ALS. Further research is needed to confirm its safety and effectiveness in humans."
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "In the case of the LiPS-A3S line, transgenes are inserted into chromosome 1."
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "There are several deep learning tools and models that can be used for predicting drug synergy. Some of the popular ones include:\n1. DeepDrug: This is a deep learning model that can predict drug synergy by analyzing the molecular structures of drugs and their targets. It uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict the synergy between drugs.\n2. Drug2Drug: This is a deep learning model that predicts drug synergy by analyzing the chemical structures of drugs. It uses a combination of CNNs and RNNs to predict the interactions between drugs and their targets, and the resulting synergy.\n3. DrugSynth: This is a deep learning model that predicts drug synergy by analyzing the chemical structures of drugs and their targets. It uses a combination of CNNs and RNNs to predict the interactions between drugs and their targets, and the resulting synergy.\n4. SynergyNet: This is a deep learning model that predicts drug synergy by analyzing the molecular structures of drugs and their targets. It uses a combination of CNNs and RNNs to predict the interactions between drugs and their targets, and the resulting synergy.\n5. ChEA-Net: This is a deep learning model that predicts drug synergy by analyzing the chemical structures of drugs and their targets. It uses a combination of CNNs and RNNs to predict the interactions between drugs and their targets, and the resulting synergy.\n6. Graph Convolutional Networks (GCNs): GCNs are a type of deep learning model that can be used to predict drug synergy by analyzing the molecular structures of drugs and their targets. They use a graph structure to represent the interactions between drugs and their targets, and can learn to predict the synergy between them.\n7. Message Passing Neural Networks (MPNNs): MPNNs are a type of deep learning model that can be used to predict drug synergy by analyzing the molecular structures of drugs and their targets. They use a message passing mechanism to represent the interactions between drugs and their targets, and can learn to predict the synergy between them.\n8. Transformer Networks: Transformer"
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "The cloud-based platform that has been developed for comparing GWAS is called \"GWAS-to-GWAS\" (G2G). G2G is a web-based platform that allows researchers to compare genetic associations between different GWAS datasets, and to identify shared genetic signals across different studies. G2G was developed by the National Center for Biotechnology Information (NCBI) and is available for use at no cost."
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "CMB305 is a monoclonal antibody that targets the CD305 receptor, which is overexpressed in many types of cancer, including sarcomas. Therefore, CMB305 has the potential to be used against sarcomas."
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The Saint's Triad, also known as the Behcet's Syndrome, is a rare inflammatory disorder that affects the skin, joints, and eyes. The main manifestations of the Saint's Triad are:\n1. Skin manifestations: The most common skin manifestations of the Saint's Triad are oral aphthous ulcers, genital ulcers, and skin nodules. The ulcers are typically painful and can occur on the lips, tongue, or in the mouth. The skin nodules are usually firm, round, and painless.\n2. Joint manifestations: The Saint's Triad can also cause joint pain and swelling, particularly in the hands and feet. The joint pain can be severe and can cause difficulty moving the affected joints.\n3. Eye manifestations: The Saint's Triad can also cause eye problems, including uveitis, iritis, and scleritis. These eye problems can cause vision loss and eye pain.\nThese manifestations can occur alone or in combination and can vary in severity from person to person. It's important to note that the Saint's Triad is a rare condition and not everyone will experience all of these manifestations. If you are experiencing any of these symptoms, it's important to consult with a healthcare professional for proper diagnosis and treatment."
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "Overexpression of LY6K is associated with poorer prognosis in non-small cell lung cancer (NSCLC) patients."
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "During cytokinesis, the CDK (cyclin-dependent kinase) inhibitor p21 is dephosphorylated, leading to its activation and promotion of the separation of daughter cells.\nOther CDK targets that are dephosphorylated during cytokinesis include:\n1. Cyclin-dependent kinase 1 (CDK1): Dephosphorylation of CDK1 by the protein phosphatase Cdc25A is important for the progression of mitosis and the separation of daughter cells.\n2. Cyclin-dependent kinase 2 (CDK2): Dephosphorylation of CDK2 by the protein phosphatase Cdc25A is also important for the progression of mitosis and the separation of daughter cells.\n3. Cyclin-dependent kinase 4 (CDK4): Dephosphorylation of CDK4 by the protein phosphatase Cdc25A is important for the progression of mitosis and the separation of daughter cells.\n4. Cyclin-dependent kinase 6 (CDK6): Dephosphorylation of CDK6 by the protein phosphatase Cdc25A is important for the progression of mitosis and the separation of daughter cells.\n5. Cyclin-dependent kinase 9 (CDK9): Dephosphorylation of CDK9 by the protein phosphatase Cdc25A is important for the progression of mitosis and the separation of daughter cells.\nThese dephosphorylation events play a crucial role in regulating the activity of CDKs during cytokinesis, allowing for the proper separation of daughter cells and ensuring the proper progression of mitosis."
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a drug that inhibits the activity of protein kinase C (PKC), which is involved in various cellular signaling pathways. Specifically, it selectively inhibits the PKC delta and PKC epsilon isoforms, which are implicated in various physiological processes such as cell proliferation, differentiation, and survival. Xanamem has been used as a research tool to study the role of PKC in various biological processes and has also been investigated as a potential therapeutic agent for the treatment of certain diseases, including cancer and neurodegenerative disorders."
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "Hof1 and Cyk3 are two proteins that interact in yeast and play a role in the regulation of various cellular processes, including cell division, metabolism, and stress response. The interaction between Hof1 and Cyk3 is important for the proper functioning of these processes."
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "T-UCRs (tumor-associated circular RNAs) have been implicated in gastric cancer, including:\n1. Circular RNA 00107 (circRNA00107): Up-regulated in gastric cancer tissues and cell lines, and promotes cell proliferation and invasion.\n2. Circular RNA 00201 (circRNA00201): Down-regulated in gastric cancer tissues and cell lines, and inhibits cell proliferation and invasion.\n3. Circular RNA 00301 (circRNA00301): Up-regulated in gastric cancer tissues and cell lines, and promotes cell proliferation and migration.\n4. Circular RNA 00401 (circRNA00401): Down-regulated in gastric cancer tissues and cell lines, and inhibits cell proliferation and invasion.\n5. Circular RNA 00501 (circRNA00501): Up-regulated in gastric cancer tissues and cell lines, and promotes cell proliferation and migration.\n6. Circular RNA 00601 (circRNA00601): Down-regulated in gastric cancer tissues and cell lines, and inhibits cell proliferation and invasion.\n7. Circular RNA 00701 (circRNA00701): Up-regulated in gastric cancer tissues and cell lines, and promotes cell proliferation and migration.\n8. Circular RNA 00801 (circRNA00801): Down-regulated in gastric cancer tissues and cell lines, and inhibits cell proliferation and invasion.\n9. Circular RNA 00901 (circRNA00901): Up-regulated in gastric cancer tissues and cell lines, and promotes cell proliferation and migration.\n10. Circular RNA 01001 (circRNA01001): Down-regulated in gastric cancer tissues and cell lines"
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a clinical index used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that affects multiple organ systems. The LSI is a composite measure that takes into account various clinical and laboratory parameters, including:\n1. Serum creatinine level\n2. Urinary protein-to-creatinine ratio\n3. Levels of certain autoantibodies (such as anti-double-stranded DNA and anti-smooth muscle antibodies)\n4. Disease activity score (using a combination of joint count, tender joint count, and swollen joint count)\n5. Patient global assessment of disease severity\n6. Physician global assessment of disease severity\n7. Organ involvement (based on physical examination and laboratory tests)\nThe LSI scores are calculated based on the values of these parameters, and the total score ranges from 0 to 100. Higher scores indicate more severe disease. The LSI has been shown to be a useful tool for assessing the severity of SLE and monitoring the response to treatment."
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "ZSWIM6 is a gene that has been associated with various neurological disorders, including:\n1. Neurodevelopmental disorders: De novo mutations in ZSWIM6 have been identified in individuals with neurodevelopmental disorders, such as intellectual disability, autism spectrum disorder, and attention deficit hyperactivity disorder (ADHD).\n2. Epilepsy: ZSWIM6 mutations have been found to be associated with various forms of epilepsy, including infantile spasms, Lennox-Gastaut syndrome, and other types of epilepsy.\n3. Seizures: De novo mutations in ZSWIM6 have been identified in individuals with seizure disorders, including those with no known genetic cause.\n4. Brain malformations: ZSWIM6 mutations have been found to be associated with various brain malformations, including cortical malformations and hydrocephalus.\n5. Developmental delay: De novo mutations in ZSWIM6 have been identified in individuals with developmental delay, including those with global developmental delay and speech and language disorders.\nIt is important to note that the frequency and severity of these disorders may vary depending on the specific mutation and the individual affected."
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "The Koos Classification is a system used to classify neurodegenerative diseases based on the type of protein aggregates present in the brain. The diseases that can be classified using the Koos Classification are:\n1. Alzheimer's disease (AD): characterized by the presence of amyloid-β (Aβ) peptide aggregates.\n2. Parkinson's disease (PD): characterized by the presence of α-synuclein (α-syn) aggregates.\n3. Progressive supranuclear palsy (PSP): characterized by the presence of tau protein aggregates.\n4. Multiple system atrophy (MSA): characterized by the presence of α-syn aggregates.\n5. Frontotemporal dementia (FTD): characterized by the presence of TDP-43 protein aggregates.\nIt's worth noting that this classification system is not exhaustive and there are other neurodegenerative diseases that can also be classified using this system, but these are the main ones."
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a small molecule inhibitor of the enzyme PI3K (phosphatidylinositol 3-kinase). In vivo, AZD8601 has been shown to have a range of effects, including:\n1. Inhibition of tumor growth: AZD8601 has been shown to inhibit the growth of various types of tumors, including breast, lung, and colon cancer, both in vitro and in vivo.\n2. Induction of apoptosis: AZD8601 has been shown to induce apoptosis (programmed cell death) in cancer cells, which can lead to a decrease in tumor size.\n3. Inhibition of angiogenesis: AZD8601 has been shown to inhibit the formation of new blood vessels, which are necessary for tumor growth and survival.\n4. Enhancement of chemotherapy: AZD8601 has been shown to enhance the effectiveness of chemotherapy drugs in treating cancer, both in vitro and in vivo.\n5. Reduction of cancer stem cell population: AZD8601 has been shown to reduce the population of cancer stem cells, which are thought to be responsible for the initiation and maintenance of cancer.\n6. Immune modulation: AZD8601 has been shown to modulate the immune response, including the activation of immune cells and the production of cytokines.\n7. Anti-inflammatory effects: AZD8601 has been shown to have anti-inflammatory effects, including the inhibition of the production of pro-inflammatory cytokines.\n8. Neuroprotection: AZD8601 has been shown to have neuroprotective effects, including the protection of neurons against oxidative stress and excitotoxicity.\nIt is important to note that the specific effects of AZD8601 can vary depending on the type of cancer and the stage of disease, as well as the individual patient. Further research is needed to fully understand the in vivo effects of AZD8601 and its potential as a therapeutic agent."
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFs (Spatially-Arranged High-Fidelity Structures) are created through a process called \"chromatin remodeling,\" which involves the movement of nucleosomes along the DNA strand to create specific spatial arrangements of nucleosomes. This process is mediated by enzymes called chromatin remodelers, which use energy from ATP hydrolysis to move nucleosomes along the DNA strand. The specific arrangement of nucleosomes in SAHFs can have a significant impact on gene expression, as it can alter the accessibility of transcription factors and other regulatory proteins to the underlying DNA."
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "The PDZ (PSD-95/Discs-Large/ZO-1) domain is a protein-binding domain found in the SATB1 protein. The PDZ domain of SATB1 is involved in the regulation of chromatin remodeling and transcriptional activation. It interacts with other proteins, such as PML and histone deacetylases, to modulate their activity and play a role in the regulation of gene expression, particularly during embryonic development and cell differentiation."
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "The BLISS (Blocking, Loading, Isolation, and Separation of Signaling) technique is a method used to isolate and analyze protein-protein interactions (PPIs) in a cellular context. The basis of the BLISS technique is to use a combination of chemical and biochemical methods to isolate and analyze the interactions between specific protein pairs in a native cellular environment.\nThe BLISS technique consists of four main steps:\n1. Blocking: The first step is to block the activity of the proteins of interest using a specific inhibitor or small molecule. This step helps to prevent the proteins from interacting with other proteins in the cell and allows for the isolation of the specific interaction of interest.\n2. Loading: The second step is to load the proteins of interest with a fluorescent or radioactive tag. This allows for the visualization and detection of the proteins in the cell.\n3. Isolation: The third step is to isolate the proteins of interest using a combination of biochemical and cellular fractionation methods. This step helps to purify the proteins of interest and remove any non-specific interactions.\n4. Separation: The final step is to separate the proteins of interest based on their interactions using a combination of chromatography and spectroscopy methods. This step helps to identify the specific interactions between the proteins of interest and any other proteins in the cell.\nThe BLISS technique provides a powerful tool for studying PPIs in a cellular context, allowing researchers to identify and characterize specific interactions in a native and dynamic environment."
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "Here are three NK3R antagonists:\n1. GR 127935: A potent and selective NK3R antagonist that has been shown to have potential in the treatment of various conditions, including cancer and neurological disorders.\n2. MK-0532: A highly selective and potent NK3R antagonist that has been shown to have potential in the treatment of gastrointestinal disorders, such as irritable bowel syndrome.\n3. BAY-60-2764: A potent and selective NK3R antagonist that has been shown to have potential in the treatment of various conditions, including cancer and neurological disorders."
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is LY2835219."
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "Vaxchora, a cholera vaccine made by GlaxoSmithKline, has been shown to have a protective efficacy of 70-80% against moderate to severe cholera in adults and children aged 1-50 years old, according to clinical trials."
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was the oral cholera vaccine, also known as the killed oral cholera vaccine (KOCV), which was approved by the US Food and Drug Administration (FDA) in 1993."
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the CD40 ligand gene (CD40LG). This gene provides instructions for making a protein called CD40 ligand, which is involved in the activation of immune cells and the immune response. Mutations in the CD40LG gene can lead to a deficiency in CD40 ligand production, which can result in the immune system dysfunction and the development of CVID."
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been found to be mutated in some cases of Systemic Lupus Erythematosus (SLE), and it is thought to play a role in the development and progression of the disease. Specifically, the IFIT1 gene encodes a protein called interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), which is involved in the antiviral response and the regulation of inflammation. Mutations in the IFIT1 gene have been associated with an increased risk of SLE, and it is thought that these mutations may disrupt the normal function of the IFIT1 protein, leading to an imbalance in the immune system and the development of autoantibodies."
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score (LES) is a clinical assessment tool used to evaluate the severity of elbow pain and stiffness in patients with medial epicondylitis, also known as golfer's elbow. The score is used to assess the patient's symptoms, functional ability, and quality of life, and can help guide treatment decisions. The LES consists of 5 components: pain, grip strength, range of motion, palpation, and functional ability. Each component is rated on a scale of 0-10, with higher scores indicating greater severity of symptoms. A total score of 0-20 indicates mild symptoms, 21-40 indicates moderate symptoms, and 41-60 indicates severe symptoms."
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project is a large-scale genomics initiative launched in 2015 in the UK to accelerate the diagnosis and treatment of rare and undiagnosed genetic diseases, including sarcoma. Here are some efforts on sarcoma from the 100,000 Genomes Project:\n1. Data analysis: The 100,000 Genomes Project has generated a large amount of genomic data, including whole-genome sequencing data for over 16,000 cancer patients, including sarcoma patients. Researchers are analyzing these data to identify genetic mutations and other genomic changes that may be associated with sarcoma.\n2. Identification of new sarcoma subtypes: The 100,000 Genomes Project has identified new subtypes of sarcoma, including a subtype of leiomyosarcoma that is characterized by a specific genetic mutation. This subtype is found in approximately 10% of leiomyosarcomas and may have a different prognosis and response to treatment than other subtypes.\n3. Development of new diagnostic tests: The 100,000 Genomes Project has developed new diagnostic tests that use genomic data to identify specific genetic mutations in sarcoma tumors. These tests have the potential to improve the accuracy of sarcoma diagnosis and help guide treatment decisions.\n4. Identification of potential therapeutic targets: The 100,000 Genomes Project has identified potential therapeutic targets for sarcoma treatment, including genes that are commonly mutated in sarcoma tumors. These targets may be used to develop new therapies for sarcoma, including targeted therapies and immunotherapies.\n5. Collaboration with clinicians and researchers: The 100,000 Genomes Project has collaborated with clinicians and researchers to ensure that the genomic data generated through the project is used to improve the diagnosis and treatment of sarcoma. This collaboration has helped to ensure that the data is used in a way that is clinically relevant and has the potential to make a positive impact on patient outcomes.\nIn summary"
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "No, protein ALEX1 does not contain armadillo repeats."
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "Enzymes that remove histone modifications include:\n1. Histone demethylases: These enzymes remove methyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone demethylases include KDM4B, KDM5A, and KDM5B.\n2. Histone acetyltransferases (HATs): These enzymes add acetyl groups to histone proteins, leading to changes in chromatin structure and gene expression. Examples of HATs include p300 and CBP (CREB-binding protein).\n3. Histone deacetylases (HDACs): These enzymes remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of HDACs include HDAC1, HDAC2, and HDAC3.\n4. Histone ubiquitin ligases: These enzymes remove histone proteins from chromatin by attaching ubiquitin tags, leading to changes in chromatin structure and gene expression. Examples of histone ubiquitin ligases include RING1B and RING1A.\n5. Hydroxamate-specific histone demethylases: These enzymes remove methyl groups from histone proteins in a hydroxamate-sensitive manner, leading to changes in chromatin structure and gene expression. Examples of hydroxamate-specific histone demethylases include KDM1A and KDM4B.\n6. Arginine methyltransferases: These enzymes add methyl groups to histone proteins at arginine residues, leading to changes in chromatin structure and gene expression. Examples of arginine methyltransferases include PRMT1 and PRMT5.\n7. Prolyl isomerases: These enzymes catalyze the isomerization of proline residues in histone proteins, leading to changes in chromatin structure and gene expression. Examples of prolyl isomerases include PIN1 and PIN2.\n8. Chromodomain-containing proteins: These enzymes recognize and bind to specific histone modifications, leading to changes in chromatin structure and gene expression. Examples of chromod"
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "Head CT scans do not directly increase the risk of developing a brain tumor. However, there is some evidence to suggest that repeated exposure to ionizing radiation from CT scans may increase the risk of developing a brain tumor over time. This is because ionizing radiation has the potential to damage the DNA in cells, which can lead to mutations and an increased risk of cancer.\nThe American Association of Neurological Surgeons states that the risk of developing a brain tumor from a single CT scan is low, but the risk may be higher for people who have multiple CT scans over time. However, the organization notes that the overall risk of developing a brain tumor from CT scans is still relatively low, and the benefits of the scans in diagnosing and treating medical conditions often outweigh the potential risks.\nIt's important to weigh the potential risks and benefits of CT scans on an individual basis, and to discuss any concerns with a healthcare provider. They can help determine the appropriate use of CT scans and monitor for any potential side effects."
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with neural pluripotency."
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "According to the information provided, there are 10 DNaseI hypersensitive sites (DHS) that mark the murine beta globin locus region."
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "Sure! Here are some European influenza vaccines that are currently available or have been approved in the past:\n1. Fluarix Tetra: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by GlaxoSmithKline (GSK) and is approved for use in the European Union (EU).\n2. Flulaval: This is a trivalent vaccine that protects against three strains of influenza: two A strains and one B strain. It is manufactured by Sanofi Pasteur and is approved for use in the EU.\n3. Aggrivax: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by BioProtection Systems and is approved for use in the EU.\n4. Fluad: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by Novartis and is approved for use in the EU.\n5. Vaxigrip: This is a trivalent vaccine that protects against three strains of influenza: two A strains and one B strain. It is manufactured by Sanofi Pasteur and is approved for use in the EU.\n6. Fluvirin: This is a trivalent vaccine that protects against three strains of influenza: two A strains and one B strain. It is manufactured by Novartis and is approved for use in the EU.\n7. Fluarix: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by GSK and is approved for use in the EU.\n8. Flucelvax: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by BioProtection Systems and is approved for use in the EU.\n9. Vaxigrip Tetra: This is a quadrivalent vaccine that protects against four strains of"
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the Paramyxovirus geneome is segmented, negative-sense RNA."
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "Roflumilast cream is effective for treating plaque psoriasis."
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "There are several tools that have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Here are some of the commonly used tools:\n1. CpG Island Finder: This tool identifies CpG islands in the genome, which are known to be enriched in ncRNA promoters.\n2. ProbeFinder: This tool predicts the location of probes for ncRNA transcripts in the GenBank database, which can be used to identify ncRNA promoters.\n3. RNAhybrid: This tool predicts the secondary and tertiary structure of RNA molecules, including ncRNAs, and can be used to identify potential promoter regions.\n4. Infernal: This tool uses a Bayesian approach to predict the location of ncRNA promoters based on the sequence and structure of the RNA molecule.\n5. RNApromoter: This tool uses a machine learning approach to predict the location of ncRNA promoters based on the sequence and structure of the RNA molecule.\n6. Cis-regulatory element annotation system (CREAS): This tool predicts the location of transcription factor binding sites, including those that are associated with ncRNA promoters.\n7. RNAProFinder: This tool predicts the location of ncRNA promoters based on the sequence and structure of the RNA molecule, as well as the presence of specific motifs.\n8. DeepSEA: This tool uses a deep learning approach to predict the location of ncRNA promoters based on the sequence and structure of the RNA molecule.\n9. RNApromoter-M: This tool uses a machine learning approach to predict the location of ncRNA promoters based on the sequence and structure of the RNA molecule, as well as the presence of specific motifs.\n10. Prognosticate: This tool predicts the location of ncRNA promoters based on the sequence and structure of the RNA molecule, as well as the presence of specific motifs.\nThese tools can be used to identify potential ncRNA promoters in a genome, and can be useful for understanding the regulation of"
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "SWIM (SWI/SNF Chromatin Modification) is a tool that uses chromatin immunoprecipitation sequencing (ChIP-seq) data to identify genes that are regulated by the SWI/SNF chromatin remodeling complex in various cancer types, including glioblastoma. Here are some examples of genes that SWIM has identified as down-regulated in glioblastoma:\n1. TP53: Tumor suppressor gene that is frequently mutated in glioblastoma.\n2. PTEN: Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor that is down-regulated in many types of cancer, including glioblastoma.\n3. CDKN2A: Cyclin-dependent kinase inhibitor 2A (CDKN2A) is a tumor suppressor gene that is frequently mutated or lost in glioblastoma.\n4. CDKN1A: Cyclin-dependent kinase inhibitor 1A (CDKN1A) is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma.\n5. APC: Adenomatous polyposis coli (APC) is a tumor suppressor gene that is frequently mutated in many types of cancer, including glioblastoma.\n6. BRCA1: BReast CAncer 1 (BRCA1) is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma.\n7. MLH1: MutL homolog 1 (MLH1) is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma.\n8. MSH2: MutS homolog 2 (MSH2) is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma.\n9. MSH6: MutS homolog 6 (MSH6) is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma.\n10. PML: Promyelocytic leukemia (PML) is a tum"
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for studying Topological Associated Domains (TADs), including:\n1. TADbit: This package provides a comprehensive set of tools for the analysis of TADs, including the ability to identify TAD boundaries, quantify TAD size and shape, and detect changes in TAD structure between different samples.\n2. TADtrackR: This package provides a framework for the analysis of TADs in Chromatin Immunoprecipitation sequencing (ChIP-seq) data, including the ability to identify TADs, quantify their size and shape, and detect changes in TAD structure between different samples.\n3. TADseq: This package provides a set of tools for the analysis of TADs in RNA sequencing (RNA-seq) data, including the ability to identify TADs, quantify their expression levels, and detect changes in TAD expression between different samples.\n4. TADHunter: This package provides a tool for the automatic detection of TADs in ChIP-seq data, including the ability to identify TAD boundaries, quantify TAD size and shape, and detect changes in TAD structure between different samples.\n5. TADmap: This package provides a tool for the visualization and analysis of TADs in ChIP-seq data, including the ability to create maps of TADs, visualize the distribution of TADs across the genome, and detect changes in TAD structure between different samples.\n6. TADtrack: This package provides a tool for the analysis of TADs in ChIP-seq data, including the ability to identify TAD boundaries, quantify TAD size and shape, and detect changes in TAD structure between different samples.\n7. TAD-seq: This package provides a tool for the analysis of TADs in RNA-seq data, including the ability to identify TADs, quantify their expression levels, and detect changes in TAD expression between different samples.\n8. TAD-detector: This package provides a tool for the automatic detection of TADs in ChIP-seq data, including the ability to identify TAD boundaries, quantify TAD size and shape, and detect changes in TAD structure between different samples.\n9. TAD-finder: This package provides a tool for the automatic detection of TADs in Ch"
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "The Bioconductor package \"RosettaRegulon\" has been developed for accessing bacterial regulatory networks. RosettaRegulon is a collection of tools and resources for analyzing and predicting the regulatory interactions in bacteria, including the regulatory networks, transcriptional regulatory sites, and gene expression profiles. It integrates various types of data, including genomic, transcriptomic, and proteomic data, to provide a comprehensive view of bacterial regulatory networks."
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The end products of the shikimate pathway are:\n1. Aromatic amino acids: phenylalanine, tyrosine, and tryptophan.\n2. Quinates: quinic acid and shikimate.\n3. Acids: erythrose-4-phosphate, 3-phosphoglycerate, and succinic acid.\n4. Fatty acids: acyl-CoA derivatives.\n5. Amino sugars: gentisic acid and salicinic acid.\n6. Alcohols: erythritol and sorbitol.\n7. Carboxylic acids: 3-hydroxybutyric acid and 3-hydroxyvaleric acid.\n8. Amines: putrescine and spermidine.\nPlease note that this list is not exhaustive and the end products of the shikimate pathway may vary depending on the specific organism and the stage of the pathway."
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Yes, cabergoline is sometimes used to treat Nelson's syndrome, which is a rare condition that occurs after surgical removal of a pituitary tumor. Cabergoline is a dopamine receptor agonist that can help to reduce the size of the remaining tumor tissue and alleviate symptoms such as prolactinoma, hyperprolactinemia, and visual disturbances. However, it is important to note that cabergoline is not a standard treatment for Nelson's syndrome and its use for this condition is off-label. The most common treatment for Nelson's syndrome is surgical intervention, followed by radiation therapy and medications to reduce prolactin levels."
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "Liebenberg syndrome is a rare genetic disorder characterized by progressive muscle weakness, muscle wasting, and muscle cramps, primarily affecting the limbs. The main manifestation of Liebenberg syndrome is proximal muscle weakness, which refers to the loss of muscle mass and strength in the upper arms and legs. This can lead to difficulty with walking, balance, and other daily activities. Other symptoms may include muscle cramps, spasms, and twitching, as well as a high risk of respiratory muscle weakness, which can lead to breathing difficulties."
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "There are several orally bioavailable MPS1 kinase inhibitors that have been identified and investigated for their potential therapeutic applications. Here are some examples:\n1. Ruxolitinib: Ruxolitinib is a potent and selective MPS1 inhibitor that has been approved for the treatment of myelofibrosis, a type of blood cancer. It is available in oral form and has been shown to inhibit MPS1 activity in vitro and in vivo.\n2. PF-06700600: PF-06700600 is a highly selective and potent MPS1 inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and ovarian cancer. It is currently in clinical development.\n3. BAY 80-6946: BAY 80-6946 is a small molecule inhibitor of MPS1 that has been shown to inhibit MPS1 activity in vitro and in vivo. It is currently in clinical development for the treatment of various cancers.\n4. AZD-1475: AZD-1475 is a potent and selective MPS1 inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and ovarian cancer. It is currently in clinical development.\n5. GDC-0980: GDC-0980 is a highly selective and potent MPS1 inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and ovarian cancer. It is currently in clinical development.\nIt is important to note that this list is not exhaustive and there may be other orally bioavailable MPS1 kinase inhibitors in various stages of development. Additionally, the development of these inhibitors is ongoing, and their efficacy and safety in humans have not yet been fully established."
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "Golimumab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor, is approved for the treatment of certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. However, it has not been specifically tested or approved for the treatment of diabetes."
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Progeria, also known as Hutchinson-Gilford progeria syndrome (HGPS), is caused by a mutation in the LMNA gene, which is located on chromosome 1. Progeria is an autosomal dominant disorder, meaning that a single copy of the mutated gene is enough to cause the condition. Individuals with progeria have a 50% chance of passing the mutated gene to each of their children, regardless of whether they are affected or not."
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "Common variants at 12q14 and 12q24 have been associated with various diseases and conditions, including:\n12q14:\n* Bipolar disorder: Variants in this region have been implicated in the risk of developing bipolar disorder.\n* Schizophrenia: Some studies have found associations between variants in this region and the risk of schizophrenia.\n* Major depressive disorder: Some studies have suggested that variants in this region may be associated with an increased risk of major depressive disorder.\n* Obesity: Variants in this region have been linked to an increased risk of obesity and metabolic disorders.\n12q24:\n* Prostate cancer: Variants in this region have been associated with an increased risk of prostate cancer.\n* Breast cancer: Some studies have found associations between variants in this region and an increased risk of breast cancer.\n* Colorectal cancer: Variants in this region have been linked to an increased risk of colorectal cancer.\nIt's important to note that these associations are based on observational studies and more research is needed to confirm these findings and understand the underlying mechanisms."
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "Roundabout (Robo) receptors are activated by a variety of ligands, including:\n1. Robo1 and Robo2 are activated by the ligand Roundabout (Robo), also known as Rnd1 and Rnd2.\n2. Robo3 is activated by the ligands Rho-associated protein kinase (Rock) and Dishevelled (Dvl).\n3. Robo4 is activated by the ligand Rho-GTPase-activating protein (GAP) domain-containing protein (RGAP).\nThese ligands bind to the extracellular domain of the Robo receptors, leading to their activation and modulation of downstream signaling pathways involved in cell migration, differentiation, and survival."
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "TFII-I does not play a direct role in megakaryopoiesis. TFII-I is a general transcription factor that is involved in the initiation of transcription in eukaryotic cells, but it is not specifically involved in the regulation of megakaryocyte differentiation or platelet production."
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is one of the most important enzymes responsible for the metabolism of atenolol, and it is estimated that approximately 30-40% of the drug is metabolized by this enzyme. The metabolism of atenolol by CYP2D6 can result in the formation of active metabolites, such as the beta-hydroxy and N-oxide metabolites, which contribute to the drug's therapeutic effects."
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "As a helpful assistant, I must inform you that ExpansionHunter is a fictional tool, and therefore does not have any versions. It is a term that is often used in the context of gene editing and genome engineering, but it is not a real tool or software program.\nHowever, there are several tools and software programs that are used in the field of gene editing and genome engineering, including:\n1. CRISPR-Cas9: A popular gene editing tool that uses a small RNA molecule to guide an enzyme called Cas9 to a specific location in the genome, where it can make a cut in the DNA.\n2. TALENs: Another gene editing tool that uses a DNA-binding protein to recognize a specific sequence of DNA and make a cut in the genome.\n3. ZFNs: A type of gene editing tool that uses a zinc finger protein to recognize a specific sequence of DNA and make a cut in the genome.\n4. Homology-directed repair (HDR): A process by which the cell repairs a break in the DNA by using a template with a similar sequence to the broken DNA.\n5. Non-homologous end joining (NHEJ): A process by which the cell repairs a break in the DNA by simply joining the two ends of the break without using a template.\nThese are just a few examples of the many tools and techniques that are used in gene editing and genome engineering."
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 does not play a direct role in hormone receptor signaling."
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a small molecule inhibitor of the histone acetyltransferase (HAT) enzyme p300. It works by competitively inhibiting the enzymatic activity of p300, thereby reducing the acetylation of histone proteins and altering chromatin structure, leading to changes in gene expression."
  }
]